Quarterly Report (Form 10-Q)

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

☒QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarter ended: March 31, 2022

OR

☐TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934

For the Transition Period from ___________ to____________

Commission File Number: 000-55976

OZOP ENERGY SOLUTIONS, INC.

(Exact name of registrant as specified in its charter)

Nevada		35-2540672
(State or other jurisdiction of incorporation or organization)		(I.R.S. Employer Identification No.)

42 N Main St

Florida, NY10921

(Address of principal executive offices) (zip code)

(845)544-5112

(Registrant's telephone number, including area code)

Not applicable.

(Former name, former address and former fiscal year, if changed since last report)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
None		N/A		N/A

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. ☒ Yes☐ No

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). ☒ Yes☐ No

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of "large accelerated filer," "accelerated filer" and smaller reporting company" in Rule 12b-2 of the Exchange Act.

	Large accelerated filer	☐	Accelerated filer	☐
	Non-accelerated filer	☐	Smaller reporting company	☒
	(Do not check if a smaller reporting company)		Emerging growth company	☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). ☐ Yes ☒ No

As of May 10, 2022, there were 4,622,362,977shares outstanding of the registrant's common stock, $0.001 par value per share.

OZOP ENERGY SOLUTIONS, INC.

CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

Table of Contents

	Page
Condensed Consolidated Balance Sheets as of March 31, 2022 and December 31, 2021 (Unaudited)	F-1
Condensed Consolidated Statements of Operation for the three months ended March 31, 2022 and 2021 (Unaudited)	F-2
Condensed Consolidated Statements of Stockholders' Deficit as of March 31, 2022 and 2021 (Unaudited)	F-3
Condensed Consolidated Statements of Cash Flows for the three months ended March 31, 2022 and 2021 (Unaudited)	F-5
Notes to Consolidated Financial Statements	F-6

OZOP ENERGY SOLUTIONS, INC.

CONDENSED CONSOLIDATED BALANCE SHEET

(UNAUDITED)

			March 31, 2022				December 31, 2021
ASSETS
Current Assets
Cash		$	3,636,662			$	6,767,167
Prepaid expenses			169,412				151,998
Accounts receivable			1,285,612				1,299,334
Inventory			2,336,605				1,065,982
Vendor deposits			1,469,991				874,627
Total Current Assets			8,898,282				10,159,108
Operating lease right-of-use asset, net			657,339				707,686
Property and equipment, net			160,705				132,889
Other Assets			567,000				568,249
TOTAL ASSETS		$	10,283,326			$	11,567,932
LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)
Liabilities
Current Liabilities
Accounts payable and accrued expenses		$	3,824,854			$	3,246,342
Convertible notes payable, net of discounts			25,000				25,000
Current portion of notes payable, net of discounts			16,390,428				13,011,307
Customer deposits			593,034				169,849
Deferred liability			750,000				750,000
Derivative liabilities			16,601,498				20,966,701
Operating lease liability, current portion			177,858				194,366
Current portion of deferred revenues			21,451				21,451
Total Current Liabilities			38,384,123				38,385,016
Long Term Liabilities
Note payable, net of discount			389,423				389,423
Operating lease liability, net of current portion			486,008				517,890
Deferred revenue, net of current portion			19,664				25,026
TOTAL LIABILITIES			39,279,218				39,317,355
COMMITMENTS AND CONTINGENCIES
Stockholders' Equity (Deficit)
Preferred stock (10,000,000shares authorized, par value $0.001)
Series C Preferred Stock (50,000shares authorized and 2,500and shares issued and outstanding, par value $0.001)			3				3
Series D Preferred Stock (4,570shares authorized and 1,334shares issued and outstanding, par value $0.001)			1				1
Series E Preferred Stock (3,000shares authorized, -0- issued and outstanding, par value $0.001)			-				-
Common stock (4,990,000,000shares authorized par value $0.001; 4,622,362,977(2022) and 4,617,362,977(2021) shares issued and outstanding)			4,622,363				4,617,363
Common stock to be issued; 637,755shares as of March 31, 2022, and December 31, 2021			638				638
Additional paid in capital			196,594,222				196,464,222
Treasury Stock			(11,249,934	)			(11,249,934	)
Accumulated Deficit			(218,520,372	)			(217,326,611	)
Total Ozop Energy Systems, Inc. stockholders' equity (deficit)			(28,553,079	)			(27,494,318	)
Noncontrolling interest			(442,813	)			(255,105	)
TOTAL STOCKHOLDERS' EQUITY (DEFICIT)			(28,995,892	)			(27,749,423	)
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)		$	10,283,326			$	11,567,932

See notes to condensed consolidated financial statements.

OZOP ENERGY SOLUTIONS, INC.

CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS

(Unaudited)

		For the Three Months Ended March 31,
		2022			2021
Revenue		$	3,082,238			$	795,554
Cost of goods sold			2,875,832				226,909
Gross profit			206,406				568,645
Operating expenses:
General and administrative, related parties			390,000				2,115,008
General and administrative, other			1,587,857				3,674,462
Total operating expenses			1,977,857				5,789,470
Loss from operations			(1,771,451	)			(5,220,825	)
Other (income) expenses:
Interest expense			3,975,221				40,654,750
(Gain) loss on change in fair value of derivatives			(4,365,203	)			52,197,902
Loss on extinguishment of debt			-				94,968,891
Debt restructure expense			-				16,450,000
Total Other (Income) Expenses			(389,982	)			204,271,543
Loss before income taxes			(1,381,469	)			(209,492,368	)
Income tax provision			-				-
Net Loss			(1,381,469	)			(209,492,368	)
Less: net loss attributable to noncontrolling interest			(187,708	)			-
Net loss attributable to Ozop Energy Solutions, Inc.		$	(1,193,761	)		$	(209,492,368	)
Loss per share basic and fully diluted		$	(0.00	)			(0.05	)
Weighted average shares outstanding
Basic and diluted			4,619,807,422				3,978,009,658

See notes to condensed consolidated financial statements.

OZOP ENERGY SOLUTIONS, INC.

CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIT)

THREE MONTHS ENDED MARCH 31, 2022

(Unaudited)

		Common stock			Series C Preferred			Series D Preferred								Additional						Non			Total Stockholders'
		to be issued			Stock			Stock			Common Stock			Treasury			Paid-in			Accumulated			controlling			Equity
		Shares			Amount			Shares			Amount			Shares			Amount			Shares			Amount			Stock			Capital			Deficit			Interest			(Deficit)
Balances January 1, 2022			637,755			$	638				2,500			$	3				1,334			$	1				4,617,362,977			$	4,617,363			$	(11,249,934	)	$	196,464,222			$	(217,326,611	)		$	(255,105	)		$	(27,749,423	)
Common stock issued for services			-				-				-				-				-				-				5,000,000				5,000								130,000				-				-				135,000
Net loss			-				-				-				-				-				-				-				-				-				-				(1,193,761	)			(187,708	)			(1,381,469	)
Balances March 31, 2022			637,755			$	638				2,500			$	3				1,334			$	1				4,622,362,977			$	4,622,363			$	(11,249,934	)		$	196,594,222			$	(218,520,372	)		$	(442,813	)		$	(28,995,892	)

See notes to condensed consolidated financial statements.

OZOP ENERGY SOLUTIONS, INC.

CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIT)

THREE MONTHS ENDED MARCH 31, 2021

(Unaudited)

		Common stock			Series C Preferred		Series D Preferred			Series E Preferred								Accumulated			Additional						Total Stockholders'
		to be issued			Stock			Stock			Stock			Common Stock			Comprehensive			Paid-in			Accumulated			Equity
		Shares			Amount			Shares			Amount			Shares			Amount			Shares			Amount			Shares			Amount			Loss			Capital			Deficit			(Deficit)
Balances January 1, 2021			-				-				50,000			$	50				20,000			$	20				1,000			$	1				3,397,958,292			$	3,397,958			$	(7	)		$	12,530,933			$	(22,278,665	)		$	(6,349,710	)
Shares issued for conversions of note and interest payable			-				-				-				-				-				-				-				-				428,747,654				428,748				-				97,110,282				-				97,539,030
Shares issued upon cashless exercise of warrants			-				-				-				-				-				-				-				-				330,797,987				330,798				-				38,714,266				-				39,045,064
Issuance of Series E Preferred Stock			-				-				-				-				-				-				2,000				2				-				-				-				1,999,998				-				2,000,000
Redemption of Series E Preferred Stock			-				-				-				-				-				-				(3,000	)			(3	)			-				-				-				(2,999,997	)			-				(3,000,000	)
Shares issued and to be issued for fees and services			5,000,000				5,000				-				-				-				-				-				-				20,000,000				20,000				-				2,877,000				-				2,902,000
Shares issued for lease agreement			-				-				-				-				-				-				-				-				100,000,000				100,000				-				530,000				-				630,000
Shares issue for debt restructure			-				-				-				-				-				-				-				-				175,000,000				175,000				-				16,275,000				-				16,450,000
Net loss							-				-				-				-				-				-				-				-				-				7				-				(209,492,368	)			(209,492,368	)
Balances March 31, 2021			5,000,000			$	5,000				50,000			$	50				20,000			$	20				-			$	-				4,452,503,933			$	4,452,504			$	-			$	167,037,482			$	(231,771,033	)		$	(60,275,984	)

See notes to condensed consolidated financial statements.

OZOP ENERGY SOLUTIONS, INC.

CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS

(Unaudited)

		For the Three Months Ended March 31,
		2022			2021
Cash flows from operating activities:
Net loss from continuing operations		$	(1,381,469	)		$	(209,492,368	)
Adjustments to reconcile net loss to net cash used in operations
Non-cash interest expense			3,379,121				40,414,627
Amortization and depreciation			62,532				8,327
Debt restructure expense			-				16,450,000
(Gain) loss on fair value change of derivatives			(4,365,203	)			52,197,902
Loss on extinguishment of debt			-				94,968,892
Stock compensation expense			136,249				4,902,000
Changes in operating assets and liabilities:
Accounts receivable			13,722				(430,367	)
Inventory			(1,270,623	)			108,664
Prepaid expenses			(17,415	)			(111,799	)
Vendor deposits			(595,364	)			-
Accounts payable and accrued expenses			578,513				208,302
Deferred revenue			(5,363	)			-
Operating lease liabilities			(48,390	)			(1,788	)
Customer deposits			423,185				(188,518	)
Net cash used in operating activities			(3,090,504	)			(966,126	)
Cash flows from investing activities:
Purchase of office and computer equipment			(40,000	)			(35,306	)
Net cash used in investing activities			(40,000	)			(35,306	)
Cash flows from financing activities:
Proceeds from issuances of notes payable			-				12,000,000
Payments to shareholders			-				(11,591	)
Payments of principal of convertible note payable and notes payable			-				(3,089	)
Redemption of Series E Preferred Stock			-				(3,000,000	)
Net cash provided by financing activities			-				8,985,320
Net (decrease) increase in cash			(3,130,504	)			7,983,888
Cash, Beginning of period			6,767,167				1,808,476
Cash, End of period		$	3,636,663			$	9,792,364
Supplemental disclosure of cash flow information:
Cash paid for interest		$	10,075			$	16,523
Cash paid for income taxes		$	-			$	-
Schedule of non-cash Investing or Financing Activity:
Original issue discount included in notes payable		$	-			$	1,310,000
Issuance of common stock upon convertible note and accrued interest conversion		$	-			$	658,245
Issuance of common stock and preferred stock for consulting fees and compensation		$	136,249			$	4,902,000
Issuance of common stock for lease agreement		$	-			$	630,000
Issuance of common stock for debt restructuring		$	-			$	16,450,000

See notes to condensed consolidated financial statements.

OZOP ENERGY SOLUTIONS, INC.

Notes to Condensed Consolidated Financial Statements

March 31, 2022

(Unaudited)

NOTE 1 - ORGANIZATION

Business

Ozop Energy Solutions, Inc. (the" Company," "we," "us" or "our") was originally incorporated as Newmarkt Corp. on July 17, 2015, under the laws of the State of Nevada.

On October 29, 2020, the Company formed a new wholly owned subsidiary, Ozop Surgical Name Change Subsidiary, Inc., a Nevada corporation ("Merger Sub"). The Merger Sub was formed under the Nevada Revised Statutes for the sole purpose and effect of changing the Company's name to "Ozop Energy Solutions, Inc." That same day the Company entered into an Agreement and Plan of Merger (the "Merger Agreement") with the Merger Sub and filed Articles of Merger (the "Articles of Merger") with the Nevada Secretary of State, merging the Merger Sub into the Company, which were stamped effective as of November 3, 2020. As permitted by the Section 92.A.180 of the Nevada Revised Statutes, the sole purpose and effect of the filing of Articles of Merger was to change the name of the Company from Ozop Surgical Corp to "Ozop Energy Solutions, Inc."

On December 11, 2020, the Company formed Ozop Energy Systems, Inc. ("OES"), a Nevada corporation and a wholly owned subsidiary of the Company. OES was formed to be a manufacturer and distributor of renewable energy products.

On August 19, 2021, the Company formed Ozop Capital Partners, Inc. ("Ozop Capital"), a Delaware corporation. The Company is the majority shareholder of Ozop Capital with PJN Holdings LLC ("PJN"), a New York limited liability company, being the minority shareholder. Brian Conway was appointed as the sole officer and director of Ozop Capital and has voting control of Ozop Capital.

On October 29, 2021, EV Insurance Company, Inc. ("EVCO") was formed as a captive insurance company in the State of Delaware. EVCO is a wholly owned subsidiary of Ozop Capital. On January 7, 2022, EVCO filed with New Castle County, Delaware DBA OZOP Plus.

On February 25, 2022, the Company formed Ozop Engineering and Design, Inc. ("OED") a Nevada corporation, as a wholly owned subsidiary of the Company. OED was formed to become a premier engineering and lighting control design firm. OED offers product and design support for lighting and solar projects with a focus on fast lead times and technical support. OED and our partners are able to offer the resources needed for lighting, solar and electrical design projects. OED will provide customers systems to coordinate the understanding of electrical usage with the relationship between lighting design and lighting controls, by developing more efficient ecofriendly designs. We work with architects, engineers, facility managers, electrical contractors and engineers.

NOTE 2 - GOING CONCERN AND MANAGEMENT'S PLANS

The accompanying condensed consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. As of March 31, 2022, the Company had an accumulated deficit of $218,520,372and a working capital deficit of $29,485,841(including derivative liabilities of $16,601,498). As of March 31, 2022, the Company was in default of $15,369,247plus accrued interest on debt instruments due to non-payment upon maturity dates. These factors, among others, raise substantial doubt about the ability of the Company to continue as a going concern for one year from the date of the issuance of these financial statements. The accompanying financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classification of liabilities that may result from the possible inability of the Company to continue as a going concern.

In December 2019, a novel strain of coronavirus (COVID-19) emerged. Because COVID-19 infections have been reported throughout the United States, certain federal, state and local governmental authorities have issued stay-at-home orders, proclamations and/or directives aimed at minimizing the spread of COVID-19. The ultimate impact of the COVID-19 pandemic on the Company's operations is unknown and will depend on future developments, which are highly uncertain and cannot be predicted with confidence, including the duration of the COVID-19 outbreak, new information which may emerge concerning the severity of the COVID-19 pandemic, and any additional preventative and protective actions that governments, or the Company, may direct, which may result in an extended period of continued business disruption, and reduced operations. Any resulting financial impact cannot be reasonably estimated at this time but it may have a material adverse impact on our business, financial condition and results of operations. Management expects that its business will be impacted to some degree, but the significance of the impact of the COVID-19 outbreak on the Company's business and the duration for which it may have an impact cannot be determined at this time.

Management's Plans

As a public company, Management believes it will be able to access the public equities market for fund raising for product development, sales and marketing and inventory requirements as we expand our distribution in the U.S. market. On October 14, 2021, the Company received a Notice of effectiveness related to the Company's Form S-3 Registration Statement (the "Registration Statement"). Pursuant to the Registration Statement the Company may offer and sell from time to time in one or more offerings of up to thirty million dollars ($30,000,000) in aggregate offering price. We may offer these securities in amounts, at prices and on terms determined at the time of offering. As of the date of this Report the Company has not sold any securities pursuant to this Registration Statement.

On April 4, 2022, the Company and GHS Investments LLC ("GHS"). signed a Securities Purchase Agreement (the "GHS Purchase Agreement") for the sale of up to Two Hundred Million (200,000,000) shares of the Company's common stock to GHS. We may sell shares of our common stock from time to time over a six (6)- month period ending October 4, 2022, at our sole discretion, to GHS under the GHS Purchase Agreement. The purchase price shall be 85% of lowest VWAP for the ten (10) days preceding the Company's notice to GHS for the sale of the Company's common stock. On April 8, 2022, the Company filed a Prospectus Supplement to the Registration Statement dated October 14, 2021, regarding the GHS Purchase Agreement.

The Company is in negotiations with its' lenders related to the debt instruments that are currently in default, to extend the maturity dates.

OES is actively engaged in the renewable, electric vehicle ("EV"), energy storage and energy resiliency sectors. We are engaged in multiple business lines that include project development as well as equipment distribution. Our solar and energy storage projects involve large-scale battery and solar photovoltaics (PV) installations. Our utility-scale storage business model is based on an arbitrage business model in which we install multiple 1+ megawatt batteries, charge them with off-peak grid electricity under contract with the utility, then sell the power back during peak load hours at a premium, as dictated by prevailing electricity tariffs.

NOTE 3 - SUMMARY OF SIGNIFICANT ACCOUNTING PRONOUNCEMENTS

Basis of Presentation

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial statements and with the instructions to Form 10-Q and Article 8 of Regulation S-X of the SEC. Accordingly, they do not contain all information and footnotes required by accounting principles generally accepted in the United States of America for annual financial statements. In the opinion of the Company's management, the accompanying unaudited condensed consolidated financial statements contain all the adjustments necessary (consisting only of normal recurring accruals) to present the financial position of the Company as of March 31, 2022, and the results of operations and cash flows for the periods presented. The results of operations for the three months ended March 31, 2022, are not necessarily indicative of the operating results for the full fiscal year or any future period. These unaudited condensed consolidated financial statements should be read in conjunction with the financial statements and related notes thereto included in the Company's Current Report on Form 10-K/A filed on April 26, 2022.

The unaudited condensed consolidated financial statements include the accounts of the Company and Ozop Energy Systems, Inc. and the Company's other wholly owned subsidiaries PCTI, Ozop LLC, Ozop HK and Spinus, LLC ("Spinus") and the Company's majority owned subsidiary Ozop Capital Partners, Inc. All intercompany accounts and transactions have been eliminated in consolidation.

Use of Estimates

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amount of revenues and expenses during the reported period. Actual results could differ from those estimates.

Cash and Cash Equivalents

The Company considers all highly liquid investments with an original term of three months or less to be cash equivalents. These investments are carried at cost, which approximates fair value. Cash and cash equivalent balances may, at certain times, exceed federally insured limits. The Company has no cash equivalents at March 31, 2022, and December 31, 2021.

Sales Concentration and credit risk

Following is a summary of customers who accounted for more than ten percent (10%) of the Company's revenues for the three months ended March 31, 2022, and 2021, and their accounts receivable balance as of March 31, 2022:

		Sales % Three Months Ended March 31, 2022			Sales % Three Months Ended March 31, 2021			Accounts receivable balance March 31, 2022
Customer A			18.5	%			N/A			$	420,390
Customer B			14.7	%			N/A				308,345
Customer C			14.5	%			N/A				-
Customer D			13.5	%			N/A				3,835
Customer E			N/A				95	%			-

Accounts Receivable

The Company records accounts receivable at the time products and services are delivered. An allowance for losses is established through a provision for losses charged to expenses. Receivables are charged against the allowance for losses when management believes collectability is unlikely. The allowance (if any) is an amount that management believes will be adequate to absorb estimated losses on existing receivables, based on evaluation of the collectability of the accounts and prior loss experience.

Inventory

Inventories are valued at the lower of cost or net realizable value, with cost determined on the first-in, first-out basis. Inventory costs include finished goods, material, labor and manufacturing overhead. In evaluating the net realizable value of inventory, management also considers, if applicable, other factors, including known trends, market conditions, currency exchange rates and other such issues.

The components of inventories at March 31, 2022, and December 31, 2021, are as follows:

		March 31, 2022			December 31, 2021
Raw materials		$	236,959			$	234,168
Work in process			58,202				43,704
Finished goods			2,041,444				788,110
	$	2,336,605			$	1,065,982

Purchase concentration

OES purchases finished renewable energy products from its' suppliers. For the three months ended March 31, 2022, there were four suppliers that accounted for 35.7%, 24.1%, 12.6%and 10.1%, respectively. There are only a handful of major suppliers, and we currently have supply arrangements with some of those vendors. One of these vendors requires a 20%down payment with the balances due on shipment and delivery, while other vendors terms are due immediately prior to delivery. We also buy product from other distributors, if we are not able to purchase direct from the manufacturer. While management believes all of its relationships with its vendors are good, if we are unable to continue to use and/or find alternative suppliers, when we cannot buy direct, it may have a material negative effect on our business

The principal purchases by PCTI are comprised of parts and raw materials that PCTI assembles and manufactures and sells to its customers. There were no suppliers who accounted for more than ten percent (10%) of the Company's purchases for the three months ended March 31, 2021.

Property, plant and equipment

Property and equipment are stated at cost, and depreciation is provided by use of a straight-line method over the estimated useful lives of the assets.

The Company reviews property and equipment for potential impairment whenever events or changes in circumstances indicate that the carrying amounts of assets may not be recoverable. The estimated useful lives of property and equipment is as follows:

Office furniture and equipment

3-5years

Warehouse equipment

7years

Revenue Recognition

The Company recognizes revenue in accordance with ASC 606, from the commercial sales of products by: (1) identify the contract (if any) with a customer; (2) identify the performance obligations in the contract (if any); (3) determine the transaction price; (4) allocate the transaction price to each performance obligation in the contract (if any); and (5) recognize revenue when each performance obligation is satisfied. Under ASC 606, revenue is recognized when the following criteria are met: (1) persuasive evidence of an arrangement exists; (2) the performance of service has been rendered to a customer or delivery has occurred; (3) the amount of fee to be paid by a customer is fixed and determinable; and (4) the collectability of the fee is reasonably assured. Other than The Company has no outstanding contracts with any of its' customers. The Company recognizes revenue when title, ownership, and risk of loss pass to the customer, all of which occurs upon shipment or delivery of the product and is based on the applicable shipping terms.

For contracts with customers, ownership of the goods and associated revenue are transferred to customers at a point in time, generally upon shipment of a product to the customer or receipt of the product by the customer and without significant judgments. Advance payments are typically required for commercial customers and are recorded as current liability until revenue is recognized. Advance payments are not required for government customers. The majority of contracts typically require payment within 30 to 60 days after transfer of ownership to the customer.

For the periods covered herein, we did not have post shipment obligations such as training or installation, customer acceptance provisions, credits and discounts, rebates and price protection, or other similar privileges.

The following table disaggregates our revenue by major source for the three months ended March 31, 2022 and 2021:

		Three months ended March 31, 2022			Three months ended March 31, 2021
Sourced and distributed products		$	2,919,322			$	-
Manufactured products			162,916				795,554
Total		$	3,082,238			$	795,554

Revenues from sourced and distributed products are purchased from suppliers as finished goods and the Company brings the finished goods into our California warehouse to fill orders as well as to build inventory for future sales orders. From time to time for some of our larger orders we may have our suppliers ship directly to our customers to avoid extra shipping charges. For manufactured products, there is usually a bidding process by branches of the military or other large firms that need mostly battery charging and storage systems for large industrial projects. We would then purchase the raw materials and parts needed to build out the project in our Pennsylvania warehouse.

Advertising and Marketing Expenses

The Company expenses advertising and marketing costs as incurred. For the three months ended March 31, 2022, and 2021, the Company recorded advertising and marketing expenses of $3,263and $22,590, respectively.

Research and Development

Costs and expenses that can be clearly identified as research and development are charged to expense as incurred. For the three months ended March 31, 2022, and 2021, the Company did not record any research and development expenses.

Convertible Instruments

The Company evaluates and accounts for conversion options embedded in convertible instruments in accordance with ASC 815, Derivatives and Hedging Activities.

Applicable GAAP requires companies to bifurcate conversion options from their host instruments and account for them as free-standing derivative financial instruments according to certain criteria. The criteria include circumstances in which (a) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract, (b) the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not re-measured at fair value under other GAAP with changes in fair value reported in earnings as they occur and (c) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument.

The Company accounts for convertible instruments (when it has been determined that the embedded conversion options should not be bifurcated from their host instruments) as follows: The Company records, when necessary, discounts to convertible notes for the intrinsic value of conversion options embedded in debt instruments based upon the differences between the fair value of the underlying common stock at the commitment date of this note transaction and the effective conversion price embedded in this note. Debt discounts under these arrangements are amortized over the term of the related debt to their stated date of redemption.

The Company accounts for the conversion of convertible debt when a conversion option has been bifurcated using the general extinguishment standards. The debt and equity linked derivatives are removed at their carrying amounts and the shares issued are measured at their then-current fair value, with any difference recorded as a gain or loss on extinguishment of the two separate accounting liabilities.

Fair Value of Financial Instruments

The Company measures assets and liabilities at fair value based on an expected exit price as defined by the authoritative guidance on fair value measurements, which represents the amount that would be received on the sale of an asset or paid to transfer a liability, as the case may be, in an orderly transaction between market participants. As such, fair value may be based on assumptions that market participants would use in pricing an asset or liability. The authoritative guidance on fair value measurements establishes a consistent framework for measuring fair value on either a recurring or nonrecurring basis whereby inputs, used in valuation techniques, are assigned a hierarchical level.

The following are the hierarchical levels of inputs to measure fair value:

	●	Level 1 - Observable inputs that reflect quoted market prices in active markets for identical assets or liabilities.
	●	Level 2 - Inputs reflect quoted prices for identical assets or liabilities in markets that are not active; quoted prices for similar assets or liabilities in active markets; inputs other than quoted prices that are observable for the assets or liabilities; or inputs that are derived principally from or corroborated by observable market data by correlation or other means.
	●	Level 3 - Unobservable inputs reflecting the Company's assumptions incorporated in valuation techniques used to determine fair value. These assumptions are required to be consistent with market participant assumptions that are reasonably available.

From time to time, certain of the Company's embedded conversion features on debt and outstanding warrants have been treated as derivative liabilities for accounting purposes under ASC 815 due to insufficient authorized shares to fully settle conversion features of the instruments if exercised. In this case, the Company utilized the latest inception date sequencing method to reclassify outstanding instruments as derivative instruments. These contracts were recognized at fair value with changes in fair value recognized in earnings until such time as the conditions giving rise to such derivative liability classification were settled.

The carrying amounts of the Company's financial assets and liabilities, such as cash, prepaid expenses, other current assets, accounts payable and accrued expenses, certain notes payable and notes payable - related party, approximate their fair values because of the short maturity of these instruments.

The following table represents the Company's derivative instruments that are measured at fair value on a recurring basis as of March 31, 2022, and December 31, 2021, for each fair value hierarchy level:

March 31, 2022		Derivative Liabilities			Total
Level I		$	-			$	-
Level II		$	-			$	-
Level III		$	16,601,498			$	16,601,498

December 31, 2021		Derivative Liabilities			Total
Level I		$	-			$	-
Level II		$	-			$	-
Level III		$	20,966,701			$	20,966,701

Leases

The Company accounts for leases under ASU 2016-02 (see Note 14), applying the package of practical expedients to leases that commenced before the effective date whereby the Company elected to not reassess the following: (i) whether any expired or existing contracts contain leases; (ii) the lease classification for any expired or existing leases; and (iii) initial direct costs for any existing leases. For contracts entered into on or after the effective date, at the inception of a contract the Company assess whether the contract is, or contains, a lease. Our assessment is based on: (1) whether the contract involves the use of a distinct identified asset, (2) whether we obtain the right to substantially all the economic benefit from the use of the asset throughout the period, and (3) whether we have the right to direct the use of the asset. We allocate the consideration in the contract to each lease component based on its relative stand-alone price to determine the lease payments.

Operating lease ROU assets represent the right to use the leased asset for the lease term and operating lease liabilities are recognized based on the present value of the future minimum lease payments over the lease term at commencement date. As most leases do not provide an implicit rate, the Company used an incremental borrowing rate of 7.5%, for the existing lease, based on the information available at the adoption date in determining the present value of future payments. Operating lease expense is recognized pursuant to on a straight-line basis over the lease term and is included in rent in the condensed consolidated statements of operations.

Income Taxes

Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. A valuation allowance on deferred tax assets is established when management considers it is more likely than not that some portion or all of the deferred tax assets will not be realized.

Tax benefits from an uncertain tax position are only recognized if it is more likely than not that the tax position will be sustained on examination by the taxing authorities, based on the technical merits of the position. The tax benefits recognized in the financial statements from such a position are measured based on the largest benefit that has a greater than fifty percent likelihood of being realized upon ultimate resolution. Interest and penalties related to unrecognized tax benefits are recorded as incurred as a component of income tax expense. The Company has not recognized any tax benefits from uncertain tax positions for any of the reporting periods presented.

Segment Policy

The Company has no reportable segments as it operates in one segment; renewable energy.

Earnings (Loss) Per Share

The Company reports earnings (loss) per share in accordance with ASC 260, "Earnings per Share." Basic earnings (loss) per share is computed by dividing net income (loss) by the weighted-average number of shares of common stock outstanding during each period. Diluted earnings per share is computed by dividing net loss by the weighted-average number of shares of common stock, common stock equivalents and other potentially dilutive securities outstanding during the period. As of March 31, 2022, and 2021, the Company's dilutive securities are convertible into approximately 7,689,322,026and 14,215,032,540, respectively, shares of common stock. The following table represents the classes of dilutive securities as of March 31, 2022, and 2021:

		March 31, 2022			March 31, 2021
Convertible preferred stock (1)			6,933,544,491				13,357,511,800
Unexercised common stock purchase warrants (1)			672,024,518				707,950,819
Convertible notes payable			2,461,916				144,569,921
Promissory note payable (1)			81,291,096
Common stock to be issued			-				5,000,000
			7,689,322,026				14,215,032,540

(1)	The potentially dilutive shares included in the above table are limited whereby the conversion or exercise cannot result in the beneficial owner holding more than 4.99% of the then outstanding shares of common stock subsequent to any conversion or exercise.

Recent Accounting Pronouncements

In August 2020, the FASB issued Accounting Standards Update ("ASU") No. 2020-06, Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging -Contracts in Entity' Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity' Own Equity ("ASU 2020-06"), which simplifies accounting for convertible instruments by removing major separation models required under current GAAP. The ASU also removes certain settlement conditions that are required for equity-linked contracts to qualify for the derivative scope exception, and it simplifies the diluted earnings per share calculation in certain areas. The Company does not believe the adoption of the ASU will have a material impact on the Company's financial position, results of operations or cash flows.

Other than the above, there have no recent accounting pronouncements or changes in accounting pronouncements during the period ended March 31, 2022, that are of significance or potential significance to the Company.

NOTE 4 - PROPERTY AND EQUIPMENT

The following table summarizes the Company's property and equipment:

		March 31, 2022			December 31, 2021
Office equipment		$	300,083			$	260,083
Less: Accumulated Depreciation			(139,378	)			(127,194	)
Property and Equipment, Net		$	160,705			$	132,889

Depreciation expense was $12,184and $8,328for the three months ended March 31, 2022, and 2021, respectively.

NOTE 5 - CONVERTIBLE NOTES PAYABLE

On July 10, 2020, PCTI (the accounting acquirer) assumed the balance of a past-due 15% convertible note issued by the Company on September 13, 2017. As of March 31, 2022, and December 31, 2021, the outstanding principal balance of this note was $25,000.

NOTE 6 - DERIVATIVE LIABILITIES

The Company determined the conversion feature of the convertible notes, which all contain variable conversion rates, represented an embedded derivative since the notes were convertible into a variable number of shares upon conversion. Accordingly, the notes are not considered to be conventional debt under ASC 815 and the embedded conversion feature was bifurcated from the debt host and accounted for as a derivative liability.

At any given time, certain of the Company's embedded conversion features on debt and outstanding warrants may be treated as derivative liabilities for accounting purposes under ASC 815-40 due to insufficient authorized shares to settle these outstanding contracts. Pursuant to SEC staff guidance that permits a sequencing approach based on the use of ASC 815-15-25 which provides guidance for contracts that permit partial net share settlement. The sequencing approach may be applied in one of two ways: contracts may be evaluated based on (1) earliest issuance date or (2) latest maturity date. Pursuant to the sequencing approach, the Company evaluates its contracts based upon the latest maturity date.

The Company valued the derivative liabilities at March 31, 2022, and December 31, 2021, at $16,601,498and $20,966,701, respectively. For the derivative liability associated with convertible notes, the Company used the Monte Carlo simulation valuation model with the following assumptions as of March 31, 2022, and December 31, 2021, risk free interest rates at 1.06% and 0.19%, respectively, and volatility of 83% and 92%, respectively. The following assumptions were utilized in the Black-Scholes valuation at March 31, 2022, and December 31, 2021, risk free interest rate of 2.08% to 2.39%, and 48% to .99%, respectively, volatility of 226% to 331%, and 344% to 366%, respectively, and exercise prices of $0.006to $0.15.

A summary of the activity related to derivative liabilities for the three months ended March 31, 2022, is as follows:

		Derivative liabilities associated with warrants			Derivative liabilities associated with convertible notes			Total derivative liabilities
Balance December 31, 2021		$	20,938,755			$	27,946			$	20,966,701
Change in fair value			(4,365,194	)			(9	)			(4,365,203	)
Balance March 31, 2022		$	16,573,561			$	27,937			$	16,601,498

NOTE 7 - NOTES PAYABLE

The Company has the following note payables outstanding:

		March 31, 2022			December 31, 2021
Note payable bank, interest at 7.75%, matured December 5, 2021, currently in default		$	134,681			$	134,681
Note payable bank, interest at 6.5%, matured December 26, 2021, in default			344,166				344,166
Economic Injury Disaster Loan			10,000				10,000
Paycheck Protection Program loan			100,400				100,400
Notes payable, interest at 8%, matured January 5, 2020, in default			45,000				45,000
Other, due on demand, interest at 6%, currently in default			50,000				50,000
Note payable $750,000face value, interest at 12%, matured August 24, 2021, in default			375,000				375,000
Note payable $389,423face value, interest at 18%, matures November 6, 2023			389,423				389,423
Note payable $1,000,000face value, interest at 12%, matured November 13, 2021, in default			1,000,000				1,000,000
Note payable $2,200,000face value, interest at 12%, matured February 9, 2022, net of discount of $243,833(2021), in default			2,200,000				1,956,167
Note payable $11,110,000face value, interest at 12%, matured March 17, 2022, net of discount of $2,314,583(2021), in default			11,110,000				8,795,417
Note payable $3,300,000face value, interest at 12%, matures December 7, 2022, net of discount of $2,278,820(2022) and $3,099,524(2021)			1,021,180				200,476
Sub- total notes payable			16,779,851				13,400,730
Less long-term portion			389,423				389,423
Current portion of notes payable, net of discount		$	16,390,428			$	13,011,307

On December 7, 2021, the Company entered into a 12%, $3,300,000face value promissory note with a third- party lender with a maturity date ofDecember 7, 2022. In exchange for the issuance of the $3,300,000note, inclusive of an original issue discount of $300,000, the Company received proceeds of $3,000,000on December 13, 2021, from the lender. In conjunction with the note, the Company issued a warrant to purchase 75,000,000shares of common stock at $0.039per share (subject to adjustments) with an expiry date on the three- year anniversary of the note. For the three months ended Mach 31, 2022, amortization of the costs of $75,000was charged to interest expense. The fair value of the warrant calculated by the Black- Scholes option pricing method of $2,982,815has been recorded as an initial debt and an initial derivative liability of $2,982,815. For the three months ended March 31, 2022, amortization of the warrant discount of $745,704was charged to interest expense. As of March 31, 2022, and December 31, 2021, the outstanding principal balance of this note was $3,300,000with a carrying value of $1,021,180and $200,476, respectively, net of unamortized discounts of $2,278,820and $3,099,524, respectively.

On March 17, 2021, the Company entered into a 12%, $11,110,000face value promissory note with a third- party lender with a maturity date of March 17, 2022. This note is now in default. In exchange for the issuance of the $11,110,000note, inclusive of an original issue discount of $1,000,000and lender costs of $110,000the Company received proceeds of $10,000,000on March 23, 2021, from the lender. In conjunction with the note, the Company issued a warrant to purchase 250,000,000shares of common stock at $0.13per share (subject to adjustments) with an expiry date on the three- year anniversary of the note. For the three months ended March 31, 2022, amortization of the costs of $231,250was charged to interest expense. The fair value of the warrant calculated by the Black- Scholes option pricing method of $33,248,433has been recorded as an initial debt discount of $10,000,000, interest expense of $23,248,433and initial derivative liability of $32,248,433. For the three months ended March 31, 2022, amortization of the warrant discount of $2,083,333was charged to interest expense. As of March 31, 2022, and December 31, 2021, the outstanding principal balance of this note was $11,110,000with a carrying value of $11,100,000and $8,795,417, respectively, net of unamortized discounts of $2,314,583as of December 31, 2021. As of March 31, 2022, and December 31, 2021, the accrued interest is $1,362,421and $1,033,687, respectively. The Company is in discussions with the lender regarding the extension of the maturity date of this note.

On February 9, 2021, the Company entered into a 12%, $2,200,000face value promissory note with a third- party lender with a maturity date of February 9, 2022. This note is now in default. In exchange for the issuance of the $2,200,000note, inclusive of an original issue discount of $200,000the Company received proceeds of $2,000,000on February 16, 2021, from the lender. In conjunction with the note, the Company issued a warrant to purchase 50,000,000shares of common stock at $0.15per share (subject to adjustments) with an expiry date on the three- year anniversary of the note. For the three months ended March 31, 2022, amortization of the costs of $22,167was charged to interest expense. The fair value of the warrant calculated by the Black- Scholes option pricing method of $17,659,506has been recorded as an initial debt discount of $2,000,000, interest expense of $15,659,506and initial derivative liability of $17,659,506. For the three months ended March 31, 2022, amortization of the warrant discount of $221,667was charged to interest expense. As of March 31, 2022, and December 31, 2021, the outstanding principal balance of this note was $2,200,000with a carrying value as of December 31, 2021, of $1,956,167, net of unamortized discounts of $243,833. As of March 31, 2022, and December 31, 2021, the accrued interest is $295,825and $230,729, respectively. The Company is in discussions with the lender regarding the extension of the maturity date of this note.

On November 13, 2020, the Company entered into a 12%, $1,000,000face value promissory note with a third-party due November 13, 2021. Principal payments shall be made in six instalments of $166,667 commencing 180 days from the issue date and continuing each 30 days thereafter for 5 months and the final payment of principal and interest due on the maturity date. The Company received proceeds of $890,000on November 20, 2020, and the Company reimbursed the investor for expenses for legal fees and due diligence of $110,000.. In conjunction with this note, the Company issued 2 common stock purchase warrants; each warrant entitles the Holder to purchase 125,000,000shares of common stock at an exercise price of $0.008, subject to adjustments and expires on the five-year anniversary of the issue date. As of March 31, 2022 and December 31, 2021, the outstanding principal balance of this note was $1,000,000. This note is in default and the interest rate from the date of default is the lesser of 24% or the highest amount permitted by law. As of March 31, 2022, and December 31, 2021, the accrued interest is $194,630and $135,452, respectively. The Company is in discussions with the lender regarding the extension of the maturity date of this note.

On November 6, 2020, the Company entered into a Settlement Agreement with the holder of $120,000of convertible notes with accrued and unpaid interest of $8,716and a $210,000Promissory Noted dated June 23, 2020 with accrued and unpaid interest of $15,707. The Company issued a new 12% Promissory Note with a face value of $389,423and a maturity date ofNovember 6, 2023. In conjunction with this settlement, the Company issued a warrant to purchase 60,000,000shares of common stock at an exercise price of $0.0075, subject to adjustments and expires on the five-year anniversary of the issue date. The Company analyzed the transaction and concluded that this was a modification to the existing debt. The investor exercised the warrant on January 14, 2021.

On October 26, 2016, PCTI entered into a $210,000note payable with a bank. On March 15, 2021, due to defaults with the terms of the note, the note was amended with the outstanding balance due December 5, 2021, and the interest rate changed to 7.75%. Borrowings are collateralized by substantially all of the assets of PCTI and the personal guarantee of PCTI's former President. As of December 31, 2021, and December 31, 2020, $134,681and $151,469, respectively, was outstanding on the note payable. This note is in default. On April 19, 2022, PCTI received a Notice of Default, Demand and Reservation of Rights (the "Notice") from the bank's legal counsel. The Notice is also addressed to Catherine Chis (former President of PCTI and a guarantor on the note. The Company has engaged legal counsel and they are in discussions with bank's counsel regarding a potential workout.

On March 15, 2021, PCTI renewed their $350,000promissory note with a bank that provides for borrowings of up to $350,000. Interest is due monthly and the principal is due on December 26, 2021, interest rate changed to the prime rate plus 3.25% (6.5% at March 15, 2021). Borrowings are collateralized by substantially all of the assets of PCTI and the personal guarantee of PCTI's former President. As of December 31, 2021, and December 31, 2020, $344,166and $345,211, respectively, was outstanding on the promissory note. This note is in default. On April 19, 2022, PCTI received a Notice of Default, Demand and Reservation of Rights (the "Notice") from the bank's legal counsel. The Notice is also addressed to Catherine Chis (former President of PCTI and a guarantor on the note. The Company has engaged legal counsel and they are in discussions with bank's counsel regarding a potential workout.

On August 24, 2020 (the "Issue Date"), the Company entered into a 12%, $750,000face value promissory note with a third-party (the "Holder") due August 24, 2021 (the "Maturity Date"). Principal payments shall be made in six instalments of $125,000 commencing 180 days from the Issue Date and continuing each 30 days thereafter for 5 months and the final payment of principal and interest due on the Maturity Date. The Holder shall have the right from time to time, and at any time following an event of default, as defined on the agreement, to convert all or any part of the outstanding and unpaid principal, interest and any other amounts due into fully paid and non-assessable shares of common stock of the Company, at the lower of i) the Trading Price (as defined in the agreement) during the previous five trading days prior to the Issuance Date or ii) the volume weighted average price during the five trading days ending on the day preceding the conversion date. The Company received proceeds of $663,000on August 25, 2020, and the Company reimbursed the investor for expenses for legal fees and due diligence of $87,000. For the year ended December 31, 2021, amortization of the costs of $56,188was charged to interest expense. In conjunction with this Note, the Company issued 2 common stock purchase warrants; each warrant entitles the Holder to purchase 122,950,819shares of common stock at an exercise price of $0.0061, subject to adjustments and expires on the five-year anniversary of the Issue Date. The warrants issued resulted in a debt discount of $750,000. During the year ended December 31, 2021, the Company paid $375,000to the Holder. On May 3, 2021, the Company issued 75,000,000shares of common stock to the Holder, upon the cashless exercise of a portion of the warrants. As of March 31, 2022, and December 31, 2021, the outstanding principal balance of this note was $375,000. This note is in default and the interest rate from the date of default is the lesser of 24% or the highest amount permitted by law. As of March 31, 2022, and December 31, 2021, the accrued interest is $112,747and $90,247, respectively. The Company is in discussions with the lender regarding the extension of the maturity date of this note.

On April 20, 2020, PCTI was granted a loan from Huntington Bank in the amount of $100,400, pursuant to the Paycheck Protection Program ("PPP") under Division A, Title I of the CARES Act, which was enacted March 27, 2020. The loan matures on April 20, 2022and bears interest at a rate of 1.0% per annum, payable monthly beginning on November 20, 2020. The loan may be prepaid at any time prior to maturity with no prepayment penalties. Payments are deferred until the SBA determines the amount to be forgiven. The Company utilized the proceeds of the PPP loan in a manner which will enable qualification as a forgivable loan. On March 26, 2021, the Company received notice from Huntington Bank the they have determined that PCTI's loan forgiveness application has been approved and has been submitted to the SBA. On December 2, 2021, PCTI received a notice from Huntington Bank that the SBA has denied PCTI's application for loan forgiveness, due to inaccurate statements in the loan application as submitted by the former CEO of PCTI. The balance on this PPP loan was $100,400as of March 31, 2022, and December 31, 2021, and has been classified in notes payable.

On July 14, 2020, PCTI received $10,000grant under the Economic Injury Disaster Loan ("EIDL") program. Up to $10,000of the EIDL can be forgiven as long as such funds were utilized to provide working capital. The first payment due is deferred one year. The loan balance of March 31, 2022, and December 31, 2021 was $10,000 and has been classified in notes payable.

NOTE 8 - DEFERRED LIABILITY

On September 2, 2020, PCTI entered into an agreement with a third- party. Pursuant to the terms of the agreement, in exchange for $750,000, PCTI agreed to pay the third-party a perpetual three percent (3%) payment of revenues, as defined in the agreement. Payments are due ninety (90) days after each calendar quarter, with the first payment due on or before March 31, 2021, for revenues for the quarter ending December 31, 2020. The Company has recorded the $750,000as deferred liability on the March 31, 2022, and December 31, 2021, condensed consolidated balance sheet. No payments have been made and the Company is in default of the agreement. On February 26, 2021, the agreement was assigned to Ozop and on March 4, 2021, the note was amended, whereby in exchange for 175,000,000shares of common stock, the royalty percentage was amended to 1.8%. The Company valued the shares at $0.094per share (the market value of the common stock on the date of the agreement) and recorded $16,450,000as debt restructure expense on the condensed consolidated statement of operations for the three months ended March 31, 2021.

NOTE 9 - DEFERRED REVENUE

During the year ended December 31, 2020, the Company received $64,353form a customer for a payment of a three- year extended warranty. The extended warranty period is from, March 2021 through February 2024, and accordingly the Company will recognize the revenue over such period. For the three months ended March 31, 2022, and 2021, the Company recognized $5,363and $xxxx, respectively, of revenue. Of the remaining deferred revenue of $41,115, $21,451is recognized as the current portion of deferred revenue and $19,664is classified as a long- term liability on the condensed consolidated financial statements. As of December 31, 2021, $21,451is classified as the current portion and $25,026is classified as a long- term liability on the condensed consolidated financial statements.

NOTE 10 - RELATED PARTY TRANSACTIONS

Employment Agreement

On July 10, 2020, pursuant to the PCTI transaction, the Company assumed an employment contract entered into on February 28, 2020, between the Company and Mr. Conway (the "Employment Agreement"). Mr. Conway's compensation as adjusted was $20,000per month, and effective September 1, 2021, Mr. Conway receives $10,000per month from Ozop Capital.

Effective January 1, 2022, the Company entered into a new employment agreement with Mr. Conway. Pursuant to the agreement, Mr. Conway received a $250,000contract renewal bonus and will receive an annual compensation of $240,000from the Company and will also be eligible to receive bonuses and equity grants at the discretion of the BOD. The Company also agreed to compensate Mr. Conway for services provided directly to any of the Company's subsidiaries. Ozop Capital increased Mr. Conway's compensation to $20,000per month in January 2022 and OES began compensating Mr. Conway $20,000in March 2022.

Series E Preferred Stock

On March 21, 2021, the Company issued 2,000shares of Series E Preferred Stock (see Note 12), 1,800of the shares were issued to Mr. Conway. Pursuant to the terms and conditions of the Certificate of Designation of the Series E Preferred Stock, including the redemption value of $1,000per share, the Company recorded $1,800,000as stock compensation expense for the Series E shares issued to Mr. Conway. During the three months ended March 31, 2021, the Company redeemed the 1,800shares issued to Mr. Conway and recorded $1,800,000of expense related to the shares issued to Mr. Conway. On April 16, 2021, the Board of Directors (the "BOD") of the Company authorized the issuance 2,000shares of Series E Preferred stock, of which 1,050were issued to Mr. Conway.

Management Fees and related party payables

For the three months ended March 31, 2022, and 2021, the Company recorded expenses to its officers in the following amounts:

		Three months ended March 31,
		2022			2021
CEO, parent		$	390,000			$	279,999
CEO, parent- Series E Preferred Stock			-				1,800,000
President, subsidiary (resigned July 2021)			-				35,009
Total		$	125,583			$	2,115,008

Redemption of Series C and Series D Preferred Stock

On July 13, 2021, the Company entered into a Definitive Agreement (the "Agreement") with Chis to purchase the 47,500shares of the Company's Series C Preferred Stock held by Chis and the 18,667shares of the Company's Series D Preferred Stock held by Chis for the total purchase price of $11,250,000. In conjunction with the Agreement, Chis resigned from any and all positions held in the Company's wholly owned subsidiary, PCTI. Further, Chis agreed that upon her resignation and for a period of five years thereafter (the "Restriction Period"), she shall not, directly or indirectly, solicit the employment of, assist in the soliciting of the employment of, or hire any employee or officer of the Company, including those of any of its present or future subsidiaries, or induce any person who is an employee, officer, agent, consultant or contractor of the Company to terminate such relationship with the Company. Additionally, Chis agreed that during the Restriction Period, she shall not compete with the Company or PCTI anywhere worldwide or be employed by any competitor of the Company.

NOTE 11 - COMMITMENTS AND CONTINGENCIES

Leases

On January 2, 2021, the Company entered into a ten (10) year lease for a 6-bay garage storage facility of approximately2,500square feet. Pursuant to the lease the Company agreed to issue 100,000,000shares of restricted common stock. The shares were certificated on March 8, 2021, with an effective date of January 2, 2021. The Company valued the shares $0.0063, (the market value of the common stock on the date of the agreement) and has recorded $630,000as a prepaid expense. The Company has not yet taken occupancy of the space, and is in discussions with the landlord to lease a different property and applying the market value of the shares issued to the lease on the new property.

Agreements

On September 1, 2021, Ozop Capital entered into an advisory agreement (the "RMA Agreement") with Risk Management Advisors, Inc. ("RMA"). Pursuant to the terms of the RMA Agreement, RMA will assist Ozop Capital in analyzing, structuring, and coordinating Ozop Capital's participation in a captive insurance company. RMA will coordinate legal, accounting, tax, actuarial and other services necessary to implement the Company's participation in a captive insurance company, including, but not limited to, the preparation of an actuarial feasibility study, filing of all required regulatory applications, domicile selection, structural selection, and coordination of the preparation of legal documentation. In connection with the services listed above, Ozop Capital agreed to pay $50,000and to issue $50,000of shares of restricted common stock. One-half of the cash and stock were due upon the signing of the RMA Agreement. Accordingly, RMA received $25,000and 452,080shares of restricted common stock of the Company in September 2021. The balance of the cash and stock became due on October 29, 2021, upon the issuance of the captive insurance company's certificate of authority from the state of Delaware. The Company has paid the $25,000balance and recorded 637,755shares of common stock to be issued.

On April 13, 2021, the Company agreed to engage PJN Strategies, LLC ("PJN") as a consultant. Pursuant to the agreement, the Company agreed to compensate PJN $20,000per month. Effective September 1, 2021, a new agreement was entered into between PJN and Ozop Capital. Pursuant to the terms of the new one- year agreement Ozop Capital agreed to compensate PJN $84,000per month. For the three months ended March 31, 2022, the Company recorded $252,000,of consulting expenses.

On April 16, 2021, the Company signed a letter of agreement with Rubenstein Public Relations, Inc. ("RPR"). Pursuant to the letter of agreement, the Company agreed to engage RPR, effective May 1, 2021, on a month-to-month basis for $17,000per month.. The Company terminated the agreement in October 2021.

On March 30, 2021, OES hired 2 individuals as Co-Directors of Sales. Pursuant to their respective offers of employment, the Company agreed to an annual salary of $130,000with a signing bonus of $20,000for each and to issue each2,500,000shares of restricted common stock upon the execution of the agreements and every 90 days thereafter for the first year as long as the employee is still employed. The Company valued the initial shares at $0.092per share (the market price of the common stock on the date of the agreement), and $460,000is included in stock-based compensation expense for the three months ended March 31, 2021. On January 14, 2022, the Company issued each of the Co-Directors their final 2,500,000shares due. The shares were valued at $0.027per share (the market price of the common stock on the date of the issuance), and $135,000is included in stock-based compensation expense for the year ended March 31, 2022. One of the individuals resigned on January 24, 2022.

On March 15, 2021, the Company entered into a consulting agreement with Aurora Enterprises ("Aurora"). Mr. Steven Martello is a principal of Aurora. Pursuant to the agreement Mr. Martello will provide strategic analysis regarding existing markets and revenue streams as well as the development of new lines of revenue. The Company agreed to a monthly retainer fee of $10,000and to issue to Aurora or their designee 5,000,000shares of restricted common stock. The shares were issued in April 2021. Aurora designated the shares to be issued to Pegasus Partners, Inc. For the three months ended March 31, 2022, the Company has recorded $30,000of consulting expenses.

On February 24, 2021, the Company entered into a consulting agreement with Christopher Ruppel. Pursuant to the agreement Mr. Ruppel was to join the Ozop Advisory Board. During the year ended December 31, 2021, the Company issued 10,000,000shares of restricted common stock to Mr. Ruppel and agreed to a monthly fee of $2,500. The Company valued the shares at $0.2386per share (the market price of the common stock on the date of the agreement), and $2,386,000is included in stock-based compensation expense for the three months ended March 31, 2021. Effective April 1, 2021, the agreement was amended to $10,000per month. Effective May 1, 2021, the Company was no longer using the services of Mr. Ruppel. For the three months ended March 31, 2021, the Company recorded $2,500of consulting expenses.

On February 19, 2021, the Company entered into a Joint Business Alliance agreement with Grid and Energy Master Planning, LLC ("GEMM"). GEMM will provide advisory, financing and implementation solutions for behind-the-meter customers in the areas of energy efficiency, solar, EV charging, and battery storage for OES. The GEMM services allows OES to provide one-stop-shopping in these emerging and maturing sectors. As of March 31, 2022, there has not been any transactions related to this agreement and the Company is continuing to evaluate the accounting treatment of any future transactions.

On January 22, 2021, the Company issued 10,000,000shares of restricted common stock for legal services performed in 2020 and approved by the BOD of the Company on December 1, 2020. The Company valued the shares at $0.0056per share (the market price of the common stock on the date of the agreement), and $56,000is included in stock-based compensation expense for the three months ended March 31, 2021.

On January 14, 2021, the Company entered into a Consulting Agreement with Mr. Allen Sosis. Pursuant to the agreement, Mr. Sosis will provide services as the Director of Business Development for the Company's wholly owned subsidiary. Pursuant to the agreement, as amended, the Company will pay Mr. Sosis a monthly fee of $15,000and an additional $1,000in benefits. The Company also agreed to issue Mr. Sosis 5,000,000shares of restricted common stock. The shares were issued in April 2021. The Company valued the shares at $0.20per share (the market price of the common stock on the date of the agreement), and $1,000,000was recorded as deferred stock compensation, to be amortized over the one-year term of the agreement. The Company terminated Mr. Sosis's employment in October 2021, and accordingly, for the year ended December 31, 2021, $1,000,000is included in stock-based compensation expense. For the three months ended March 31, 2021, the Company recorded $45,000of consulting expenses, and effective June 1, 2021, Mr. Sosis became an employee of the Company through his termination with a $15,000per month salary.

On January 6, 2021, the Company entered into a consulting agreement with Ezra Green to begin on February 8, 2021. The Company agreed to issue 10,000,000shares of restricted common stock to Mr. Green and to a monthly fee of $2,500. The Company valued the shares at $0.0076per share (the market price of the common stock on the date of the agreement), and $76,000was recorded as deferred stock-based compensation, to be amortized over the one-year term of the agreement. Effective April 1, 2021, the agreement was amended to $10,000per month. For the three months ended March 31, 2022, and 2021, the Company recorded $30,000and $4,500, respectively, of consulting expenses.

On March 4, 2019, the Company entered into a Separation Agreement (the "Separation Agreement") with Salman J. Chaudhry, pursuant to which the Company agreed to pay Mr. Chaudry $227,200(the "Outstanding Fees") in certain increments as set forth in the Separation Agreement. As of March 31, 2022 and December 31, 2021, the balance owed Mr. Chaudhry is $162,085.

On September 2, 2020, PCTI entered into an Agreement with a third- party. Pursuant to the terms of the agreement, in exchange for $750,000, PCTI agreed to pay the third-party a perpetual three percent (3%) payment of revenues, as defined in the agreement.On February 26, 2021, the agreement was assigned to Ozop and on March 4, 2021, the agreement was amended, whereby in exchange for 175,000,000shares of common stock, the royalty percentage was amended to 1.8% (see Note 8). The Company valued the shares at $0.094per share (the market value of the common stock on the date of the agreement) and recorded $16,450,000as debt restructure expense on the condensed consolidated statement of operations for the three months ended March 31, 2021.

Legal matters

We know of no material, existing or pending legal proceedings against our Company, nor are we involved as a plaintiff in any material proceeding or pending litigation. There are no proceedings in which any of our directors, officers or affiliates, or any registered or beneficial shareholder, is an adverse party or has a material interest adverse to our interest.

NOTE 12- STOCKHOLDERS' EQUITY

Common stock

During the three months ended March 31, 2022, the Company issued 5,000,000shares of restricted common stock in the aggregate for services.

During the three months ended March 31, 2021, holders of an aggregate of $760,500in principal and $116,594of accrued interest and fees of convertible and promissory notes, converted their debt into 428,747,654shares of our common stock at an average conversion price of $0.002per share.

During the three months ended March 31 2021, the Company also issued the following shares of restricted common stock:

	●	100,000,000shares of restricted common stock pursuant to a lease agreement (see Note 11).
	●	175,000000shares of restricted common stock pursuant to restructuring agreement related to a deferred liability (see Note 9).
	●	20,000,000shares of restricted common stock in the aggregate for services and consulting agreements.

During the three months ended March 31, 2021, the Company also issued 330,797,987shares of common stock upon the cashless exercise of common stock purchase warrants.

As of March 31, 2022, the Company has 4,990,000,000shares of $0.001par value common stock authorized and there are 4,622,362,977shares of common stock issued and outstanding.

Preferred stock

As of March 31, 2022, and December 31, 2021, 10,000,000shares have been authorized as preferred stock, par value $0.001(the "Preferred Stock"), which such Preferred Stock shall be issuable in such series, and with such designations, rights and preferences as the Board of Directors may determine from time to time.

Series C Preferred Stock

On July 7, 2020, the Company filed an Amended and Restated Certificate of Designation with the State of Nevada of the Company's Series C Preferred Stock. Under the terms of the Amendment to Certificate of Designation of Series C Preferred Stock, 50,000shares of the Company's preferred remain designated as Series C Preferred Stock. The holders of Series C Preferred Stock have no conversion rights and no dividend rights. For so long as any shares of the Series C Preferred Stock remain issued and outstanding, the Holder thereof, voting separately as a class, shall have the right to vote on all shareholder matters equal to sixty-seven (67%) percent of the total vote.On July 10, 2020, pursuant to the SPA with PCTI, the Company issued 47,500shares of Series C preferred Stock to Chis. On July 13, 2021, the Company purchased 47,500shares of the Company's Series C Preferred Stock held by Chis (see Note 11). As of December 31, 2021, and 2020, there were 2,500and 50,000shares, respectively, of Series C Preferred Stock issued and outstanding, of which 2,500shares are held by Mr. Conway.

Series D Preferred Stock

On July 7, 2020, the Company filed a Certificate of Designation with the State of Nevada of the Company's Series D Preferred Stock. Under the terms of the Certificate of Designation of Series D Preferred Stock, 20,000shares of the Company's preferred stock have been designated as Series D Convertible Preferred Stock. The holders of the Series D Convertible Preferred Stock shall not be entitled to receive dividends. The holders as a group may, at any time convert all of the shares of Series D Convertible Preferred Stock into a number of fully paid and nonassessable shares of common stock determined by multiplying the number of issued and outstanding shares of common stock of the Company on the date of conversion, by 3. Except as provided in the Certificate of Designation or as otherwise required by law, no holder of the Series D Convertible Preferred Stock shall be entitled to vote on any matter submitted to the shareholders of the Company for their vote, waiver, release or other action. The Series D Convertible Preferred Stock shall not bear any liquidation rights. On July 10, 2020, pursuant to the SPA with PCTI, the Company issued 18,667shares of Series D preferred Stock to Chis, and on August 28, 2020, pursuant to Mr. Conway's employment agreement, the Company issued 1,333shares of Series D Preferred Stock to Mr. Conway. On July 13, 2021, the Company purchased 18,667shares of the Company's Series D Preferred Stock held by Chis (see Note 10).

On July 27, 2021, the Company filed with the Secretary of State of the State of Nevada an Amended and Restated Certificate of Designation of Series D Preferred Stock (the "Series D Amendment"). Under the terms of the Series D Amendment, 4,570shares of the Company's preferred stock will be designated as Series D Convertible Preferred Stock. The holders of the Series D Convertible Preferred Stock shall not be entitled to receive dividends. Any holder may, at any time convert any number of shares of Series D Convertible Preferred Stock held by such holder into a number of fully paid and nonassessable shares of common stock determined by multiplying the number of issued and outstanding shares of common stock of the Company on the date of conversion, by 1.5and dividing that number by the number of authorized shares of Series D Convertible Preferred Stock multiplied by the number of shares of Series D Convertible Preferred Stock being converted. Except as provided in the Series D Amendment or as otherwise required by law, no holder of the Series D Convertible Preferred Stock shall be entitled to vote on any matter submitted to the shareholders of the Company for their vote, waiver, release or other action. The Series D Convertible Preferred Stock shall not bear any liquidation rights. On July 28, 2021, the Company closed on a Stock and Warrant Purchase Agreement (the "Series D SPA"). Pursuant to the terms of Series D SPA, an investor in exchange for $13,200,000purchased one share of Series D Preferred Stock, and a warrant to acquire 3,236shares of Series D Preferred Stock. As of March 31, 2022, and December 31, 2021, there were 1,334, respectively, of Series D Preferred Stock issued and outstanding and warrants to purchase 3,236shares of Series D Preferred Stock are outstanding as of March 31, 2022, and December 31, 2021.

The warrant has a 15- year term and Partial Warrant Lock Up and Leak-Out Period. The Holder may only exercise the Warrant and purchase Warrant Shares as follows:

	i.	Up to 162(one hundred and sixty-two) Warrant Shares, at any time or times on or after five (5) business days from the closing of the Series D SPA ("the Initial Exercise Date") subject to up to a maximum number of Warrant Shares that, if converted, would be equal to no more than a maximum of 4.99% of the total number of outstanding shares of Common Stock of the Company and no later than on or before the 15th year anniversary of the Initial Exercise Date ("the Termination Date"); and
	ii.	The Remainder of the Warrant representing up to 3,074(three thousand and seventy-four) Warrant Shares ("Remaining Warrant Shares") shall be locked up for a period of 36 (thirty-six) months from the Initial Exercise Date ("Lock Up Period") and shall become exercisable at any time or times from the date that is the 36 (thirty-six) month anniversary of the Initial Exercise Date ("Lock Up Period Termination Date") and no later than on or before the Termination Date, as follows:

a.

During every 1(one) year period, starting on the day that is the Lock Up Period Termination Date, the Holder shall have the right to exercise the Remainder of the Warrant up to a maximum number of Remaining Warrant Shares that, if converted, would be equal to no more than a maximum of 4.99% of the total number of outstanding shares of Common Stock of the Company during such given year ("Leak-Out Period"). The Leak-Out Period shall come into effect on the day that is the Lock Up Period Termination Date and remain effective on a yearly basis, for a period of 10 (ten) years thereafter, after which the Leak-Out Period will automatically terminate and become null and void. For clarity purposes the Remainder of the Warrant shall become freely exercisable at any time or times beginning on June 29, 2034 and until the Termination Date.

Series E Preferred Stock

On July 7, 2020, the Company filed a Certificate of Designation with the State of Nevada of the Company's Series E Preferred Stock. Under the terms of the Certificate of Designation of Series E Preferred Stock, 3,000shares of the Company's preferred stock have been designated as Series E Preferred Stock. The holders of the Series E Convertible Preferred Stock shall not be entitled to receive dividends. No holder of the Series E Preferred Stock shall be entitled to vote on any matter submitted to the shareholders of the Corporation for their vote, waiver, release or other action, except as may be otherwise expressly required by law. At any time, the Corporation may redeem for cash out of funds legally available therefor, any or all of the outstanding Preferred Stock ("Optional Redemption") at $1,000(one thousand dollars) per share. The shares of Series E Preferred Stock have not been registered under the Securities Act of 1933 or the laws of any state of the United States and may not be transferred without such registration or an exemption from registration. On July 10, 2020, pursuant to the SPA with PCTI, the Company issued 500shares of Series E preferred Stock to Chis, and on August 28, 2020. Pursuant to Mr. Conway's employment agreement, the Company issued 500shares of Series E Preferred Stock to Mr. Conway. On March 2, 2021, the BOD authorized the issuance of 1,800shares of Series E Preferred Stock to Mr. Conway and 200shares of Series E Preferred Stock to a third-party service provider. The issuances were for services performed. Pursuant to the terms and conditions of the Certificate of Designation of the Series E Preferred Stock, including the redemption value of $1,000per share, the Company recorded $2,000,000as stock-based compensation expense for three months ended March 31, 2021. On March 24, 2021, the Company redeemed the 3,000shares of Series E Preferred Stock outstanding on that date. As of March 31, 2022, and December 31, 2021, there were -0- shares of Series E Preferred Stock issued and outstanding, respectively.

NOTE 13 - NONCONTROLLING INTEREST

On August 19, 2021, the Company formed Ozop Capital. Upon formation, the Company owned 51% with PJN owning 49%. Brian Conway was appointed as the sole officer and director of Ozop Capital and has voting control of Ozop Capital. The Company presents interest held by noncontrolling interest holders within noncontrolling interest in the condensed consolidated financial statements. During the three months ended March 31, 2022, there was no change in the ownership percentages. For the three months ended March 31, 2022, Ozop Capital incurred a loss of $383,077, of which $187,708is the loss attributed to the noncontrolling interest. As of March 31, 2022, the accumulative noncontrolling interest is $422,813.

NOTE 14 - OPERATING LEASE RIGHT-OF-USE ASSETS AND OPERATING LEASE LIABILITIES

On October 25, 2019, PCTI executed a non-cancellable lease for office and industrial space which began December 1, 2019 and expires on November 30, 2022. Operating lease right-of-use assets and liabilities are recognized at the present value of the future lease payments at the lease commencement date. The interest rate used to determine the present value is our incremental borrowing rate, estimated to be 7.5%, as the interest rate implicit in most of our leases is not readily determinable. Prior to July 10, 2020, PCTI recorded monthly lease expense pursuant to the lease agreement and effective July 10, 2020, pursuant to the PCTI transaction, operating lease expense is recognized pursuant to ASC Topic 842. Leases (Topic 842) over the lease term. During the years ended December 31, 2020, the Company recorded $84,278for rent expense. During the year ended December 31, 2020, upon adoption of ASC Topic 842, the Company recorded right-of-use assets and lease liabilities of $185,139for this lease.

On April 14, 2021, the Company entered into a five-year lease which began on June 1, 2021, for approximately 8,100square feet of office and warehouse space in Carlsbad, California, expiring May 31, 2026. Initial lease payments of $13,148begin on June 1, 2021, and increase by approximately 2.4% annually thereafter. The interest rate used to determine the present value is our incremental borrowing rate, estimated to be 7.5%, as the interest rate implicit in most of our leases is not readily determinable. During the year ended December 31, 2021, upon adoption of ASC Topic 842, the Company recorded right-of-use assets and lease liabilities of $702,888for this lease.

In adopting Topic 842, the Company has elected the 'package of practical expedients', which permit it not to reassess under the new standard its prior conclusions about lease identification, lease classification and initial direct costs. The Company did not elect the use-of-hindsight or the practical expedient pertaining to land easements; the latter is not applicable to the Company. In addition, the Company elected not to apply ASC Topic 842 to arrangements with lease terms of 12 months or less.

Right-of- use assets are summarized below:

		March 31, 2022
Office and warehouse lease		$	888,026
Less: Accumulated Amortization			(230,687	)
Right-of-use asset, net		$	657,339

			March 31, 2022
Lease liability		$	663,866
Less current portion			(177,858	)
Long term portion		$	486,008

Maturity of lease liabilities are as follows:

		Amount
For the year ended December 31, 2022		$	179,548
For the year ended December 31, 2023			167,858
For the year ended December 31, 2024			171,840
For the year ended December 31, 2025			175,942
For the year ended December 31, 2026			74,030
Total		$	769,218
Less present value discount			(105,352	)
Lease liability		$	663,866

NOTE 15 - SUBSEQUENT EVENTS

On April 4th, 2022, the Company and GHS Investments LLC ("GHS"). signed a Securities Purchase Agreement (the "GHS Purchase Agreement") for the sale of up to Two Hundred Million (200,000,000) shares of the Company's common stock to GHS. We may sell shares of our common stock from time to time over a six (6)- month period ending October 4, 2022, at our sole discretion, to GHS under the GHS Purchase Agreement. The purchase price shall be 85% of lowest VWAP for the ten (10) days preceding the Company's notice to GHS for the sale of the Company's common stock. On April 8, 2022, the Company filed a Prospectus Supplement to the Registration Statement dated October 14, 2021, regarding the GHS Purchase Agreement.

The Company has evaluated subsequent events through the date the financial statements were issued. The Company has determined that there are no other such events that warrant disclosure or recognition in the financial statements, except as stated herein.

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations.

The following is management's discussion and analysis of certain significant factors that have affected our financial position and operating results during the periods included in the accompanying condensed consolidated financial statements, as well as information relating to the plans of our current management. This report includes forward-looking statements. Generally, the words "believes," "anticipates," "may," "will," "should," "expect," "intend," "estimate," "continue," and similar expressions or the negative thereof or comparable terminology are intended to identify forward-looking statements. Such statements are subject to certain risks and uncertainties, including the matters set forth in this report or other reports or documents we file with the Securities and Exchange Commission from time to time, which could cause actual results or outcomes to differ materially from those projected. Undue reliance should not be placed on these forward-looking statements which speak only as of the date hereof. We undertake no obligation to update these forward-looking statements.

Although the Company believes that the expectations reflected in the forward-looking statements are reasonable, the Company cannot guarantee future results, levels of activity, performance, or achievements. Except as required by applicable law, including the securities laws of the United States, the Company does not intend to update any of the forward-looking statements to conform these statements to actual results.

Our financial statements are prepared in accordance with accounting principles generally accepted in the United States ("GAAP"). These accounting principles require us to make certain estimates, judgments, and assumptions. We believe that the estimates, judgments, and assumptions upon which we rely are reasonable based upon information available to us at the time that these estimates, judgments, and assumptions are made. These estimates, judgments, and assumptions can affect the reported amounts of assets and liabilities as of the date of the financial statements as well as the reported amounts of revenues and expenses during the periods presented. Our financial statements would be affected to the extent there are material differences between these estimates.

The following discussion should be read in conjunction with our unaudited financial statements and the related notes that appear elsewhere in this Quarterly Report on Form 10-Q.

THE COMPANY

Ozop Energy Solutions, Inc. (the "Company," "we," "us" or "our") was originally incorporated as Newmarkt Corp. on July 17, 2015, under the laws of the State of Nevada.

On December 11, 2020, the Company formed Ozop Energy Systems, Inc. ("OES"), a Nevada corporation and a wholly owned subsidiary of the Company. OES was formed to be a manufacturer and distributor of renewable energy products.

On October 29, 2020, the Company formed a new wholly owned subsidiary, Ozop Surgical Name Change Subsidiary, Inc., a Nevada corporation ("Merger Sub"). The Merger Sub was formed under the Nevada Revised Statutes for the sole purpose and effect of changing the Company's name to "Ozop Energy Solutions, Inc." That same day the Company entered into an Agreement and Plan of Merger (the "Merger Agreement") with the Merger Sub and filed Articles of Merger (the "Articles of Merger") with the Nevada Secretary of State, merging the Merger Sub into the Company, which were stamped effective as of November 3, 2020. As permitted by the Section 92.A.180 of the Nevada Revised Statutes, the sole purpose and effect of the filing of Articles of Merger was to change the name of the Company from Ozop Surgical Corp. to "Ozop Energy Solutions, Inc."

On August 19, 2021, the Company formed Ozop Capital Partners, Inc. ("Ozop Capital"), a Delaware corporation. The Company is the majority shareholder of Ozop Capital with PJN Holdings LLC, a New York limited liability company, being the minority shareholder. Ozop Capital was formed as a holding company and seeks to develop a captive insurance company. Brian Conway was appointed as the sole officer and director of Ozop Capital and has voting control of Ozop Capital.

On October 29, 2021, EV Insurance Company, Inc. ("EVCO") was formed as a captive insurer that reinsures in the State of Delaware. EVCO is a wholly owned subsidiary of Ozop Capital. On January 7, 2022, EVCO filed with New Castle County, Delaware DBA OZOP Plus.

OES is actively engaged in the renewable, electric vehicle ("EV"), energy storage and energy resiliency sectors. We are engaged in multiple business lines that include project development as well as equipment distribution. Our solar and energy storage projects involve large-scale battery and solar photovoltaics (PV) installations. Our utility-scale storage business model is based on an arbitrage business model in which we install multiple 1+ megawatt batteries, charge them with off-peak grid electricity under contract with the utility, then sell the power back during peak load hours at a premium, as dictated by prevailing electricity tariffs.

Equipment Distributor: OES has entered the component supply/distribution side of the renewable, resiliency and energy storage industries distributing the core components associated with residential and commercial solar PV systems as well as onsite battery storage and power generation. In April 2021, the Company signed a five- year lease (beginning June 1, 2021) of approximately 8,100 SF in California, for office and warehouse space to support the sales and distribution of our west coast operations. The components we are distributing include PV panels, solar inverters, solar mounting systems, stationary batteries, onsite generators and other associated electrical equipment and components that are all manufactured by multiple companies, both domestic and international. These core products are sourced from management-developed relationships and are distributed through our existing network and our in-house sales team.

Solar PV: Our PV business model involves the design and construction of electrical generating PV systems that can sell power to the utilities or be used for off grid use as part of our developing Neo-Grids solution. The Neo-Grids proprietary program, patent pending, was developed for the off-grid distribution of electricity to remove or reduce the dependency on utilities that currently burdens the EV Charging sectors. It will also reduce or eliminate the lengthy permitting processes and streamline the installations of those EV chargers.

Modular Energy Distribution System: The Neo-Grids, patent pending, is comprised of the design engineering, installation, and operational methodologies as well as the financial arbitrage of how we produce, capture and distribute electrical energy for the EV markets. : OES has acquired the license rights to a proprietary system, the Neo-Grids^TM System (patent pending), for the capture and distribution of electrical energy for the EV market. The Neo-Grids^TM Systemwill serve both the private auto and the commercial sectors. The exponential growth of the EV industry has been accelerated by the recent major commitments of most of the major car manufacturers. Our Neo-Grids^TM System leverages this accelerated growth by offering (1) charging locations that can be installed with reduced delays, restricted areas or load limits and (2) EV charger electricity that is produced from renewable sources claiming little to no carbon footprint.

OES has developed a business plan for the Neo Grids distribution, a solution to the stress forthcoming to the existing grid infrastructure. The Company has completed its' Neo Grid research and development as well as the first set of engineered technical drawings. This first stage of engineered technical drawings allows us to move forward with stage two, as well as to begin to construct the first prototype or proof of concept, ("PoC"). Our PoC design is partially reliant on auto manufacturers establishing standardizations of the actual charging/discharging protocols of the batteries such as on-board inverters as well as bi-directional capabilities in electric vehicles, which have only recently been established. As the market growth rate of EV's continues to rise, the stress on the existing grid-tied infrastructure shows the need for the continued development of our Neo-Grid solution.

OES management has decades of experience in the renewable, storage and resilient energy businesses and associated markets, which include but are not limited to project finance, project development, equipment finance, construction, utility protocol, regulatory policy and technology assessment.

Ozop Plus plans on producing vehicle service contracts ("VSC's") for electric vehicles (EV's) that will offer to consumers to be able to purchase additional months and or miles above the manufacturer's warranty and to also bring added value to EV owners by utilizing our partnerships and strengths in the energy market to offer unique and innovative services. Among EV owners' concerns are the EV battery repair and replacement costs, range anxiety, environmental responsibilities, roadside assistance, and the accelerated wear on additional components that EV vehicles experience. Management believes that the Ozop Plus VSC will give "peace of mind" to the EV buyer. The Company is currently in negotiations to complete the necessary agreements to launch the product in Q2 2022. Additionally, the Company is also in discussions with entities whereby Ozop Plus can reinsure the battery portion of another entity's VSC.

On February 25, 2022, the Company formed Ozop Engineering and Design, Inc. ("OED") a Nevada corporation, as a wholly owned subsidiary of the Company. OED was formed to become a premier engineering and lighting control design firm. OED offers product and design support for lighting and solar projects with a focus on fast lead times and technical support. OED and our partners are able to offer the resources needed for lighting, solar and electrical design projects. OED will provide its' customers systems to coordinate the understanding of electrical usage with the relationship between lighting design and lighting controls, by developing more efficient ecofriendly designs by working with architects, engineers, facility managers, electrical contractors and engineers.

Stock Purchase Agreement

On July 10, 2020, the Company entered into a Stock Purchase Agreement (the "SPA") with Power Conversion Technologies, Inc., a Pennsylvania corporation ("PCTI"), and Catherine Chis ("Chis"), PCTI's Chief Executive Officer ("CEO") and its sole shareholder. Under the terms of the SPA, the Company acquired one thousand (1,000) shares of PCTI, which represents all of the outstanding shares of PCTI, from Chis in exchange for the issuance of 47,500 shares of the Company's Series C Preferred Stock, 18,667 shares of the Company's Series D Preferred Stock, and 500 shares of the Company's Series E Preferred Stock to Chis. The Acquisition is being accounted for as a business combination and was treated as a reverse acquisition for accounting purposes with PCTI as the accounting acquirer in accordance with Financial Accounting Standards Board Accounting Standards Codification Topic 805, Business Combinations ("ASC 805"). In accordance with the accounting treatment for a reverse acquisition, the Company's historical financial statements prior to the reverse merger were and will be replaced with the historical financial statements of PCTI prior to the reverse merger, in all future filings with the U.S. Securities and Exchange Commission (the "SEC"). The consolidated financial statements after completion of the reverse merger have and will include the assets, liabilities and results of operations of the combined company from and after the closing date of the reverse merger.

PCTI designs, develops, manufactures and distributes standard and custom power electronic solutions. All of its products are manufactured in the United States.

The results of operations below include PCTI activity for the three months ended March 31, 2022, and 2021. Due to supply chain issues and other factors, management is currently reviewing the current business model of PCTI, in determining the best course of action going forward.

Stock Redemption Agreement

On July 13, 2021, the Company entered into a Definitive Agreement (the "Agreement") with Chis to purchase the 47,500 shares of the Company's Series C Preferred Stock held by Chis and the 18,667 shares of the Company's Series D Preferred Stock held by Chis for the total purchase price of $11,250,000.The Agreement was closed on July XX, 2022.

Results of Operations for the three months ended March 31, 2022 and 2021:

Revenue

For the three months ended March 31, 2022, the Company generated revenue of $3,082,238 compared to $795,554 for the three months ended March 31, 2021. The increase in revenues is a result of revenues of $2,912,322 from Ozop Energy Systems, Inc. ("OES") and are classified as sourced and distributed products. PCTI sales decreased to $162,916 for the three months ended March 31, 2022 compared to $795,554 for the three months ended March 31, 2021. Sales are summarized as follows:

		Three months ended March 31,
		2022			2021
Sourced and distributed products		$	2,912,322			$	-
Manufactured products			162,916				795,554
Total		$	3,082,238			$	795,554

As it did for most of the industry; OES's importing of solar panels issues that began in the 4^th quarter of 2021, continued into the first quarter of 2022. Covid issues continued to be distributive to a continual source of product from foreign manufacturers as well as ocean freight backlogs and covid issues that plagued the port of arrivals related to the unloading of containers and the eventual customs clearance of the imported goods. An announcement by the U.S. Department in March 2022 stated it would investigate allegations that solar panel manufacturers in Southeast Asia are using Chinese-made parts and evading U.S. tariffs has raised alarms concerning both trade and environmental policy The department announced March 28 that it would investigate claims by California-based solar panel manufacturer that solar energy equipment manufacturers in Cambodia, Malaysia, Thailand and Vietnam have close business ties to companies in China that produce the raw materials and some components of solar panel assemblies. Based on the current situation, management has placed approximately $10,900,000 of purchase orders and as of the date of the filing of this report has made approximately $1.7 million of down payments to vendors to assure product delivery of approximately $5.9 million with a forecasted delivery by August 2022 and $5 million with a forecasted delivery in November 2022. Based on the above and the Company's current on-hand inventory, management anticipates similar to slightly higher quarterly sales results for the second and third quarter of 2022 as experienced in the first quarter, and a significant increase in the fourth quarter of 2022.

Due to supply chain issues and other factors, management is currently reviewing the current business model of PCTI, in determining the best course of action going forward.

Cost of sales

For the three months ended March 31, 2022, and 2021, the Company recognized $2,875,832 and $226,909, respectively, of cost of sales.

		Three months ended March 31,
		2022			2021
Sourced and distributed products		$	2,749,349			$	-
Manufactured products			126,483				226,909
Total		$	2,875,832			$	226,909

Based on the above cost of sales, gross margin was 6.7% and 71.5% for the three months ended March 31, 2022, and 2021, respectively. The decrease of gross margin for the current year is a result of the manufactured orders shipped in 2021 were at a higher margin than the manufactured orders were in 2022. While PCTS's margin and gross profit decreased in the current year, the Company realized an additional $169,972 of gross profit dollars recognized on OES's sourced and distributed products. Due to product availability, increased buy prices and delivery issues that the solar industry experienced at the end of the 4^th quarter 2021, and into the first quarter of 2022, the Company expects that margins on sourced products may be temporarily reduced at the beginning of 2022. However, the Company anticipates that margins of sourced products will rise during the remainder of 2022. While the overall margin will be reduced, the higher gross profit dollars generated from the higher sourced and distributed products revenues will benefit the Company.

Operating expenses

Total operating expenses for the three months ended March 31, 2022, and 2021, were $1,977,857 and $5,789,470, respectively. The operating expenses were comprised of:

		Three Months Ended March 31,
		2022			2021
Wages and management fees, related parties		$	390,000			$	315,008
Stock-based compensation			136,249				4,902,000
Salaries, taxes and benefits			360,281				186,575
Professional and consulting fees			634,997				203,425
Advertising and marketing			3,263				22,590
Rent and office expenses			90,573				41,394
Insurance			94,155				12,075
General and administrative, other			268,339				106,403
Total		$	1,977,857			$	5,789,470

Wages and management fees- related parties, include amounts paid to our CEO and to the President (resigned July 2021) of PCTI. On July 10, 2020, pursuant to the PCTI transaction, the Company assumed an employment contract entered into on February 28, 2020, between the Company and Mr. Conway (the "Employment Agreement"). Mr. Conway's compensation as adjusted was $20,000 per month, and effective September 1, 2021, Mr. Conway receives $10,000 per month from Ozop Capital. Effective January 1, 2022, the Company entered into a new employment agreement with Mr. Conway. Pursuant to the agreement, Mr. Conway received a $250,000 contract renewal bonus and will receive an annual compensation of $240,000 from the Company and will also be eligible to receive bonuses and equity grants at the discretion of the BOD. The Company also agreed to compensate Mr. Conway for services provided directly to any of the Company's subsidiaries. Ozop Capital increased Mr. Conway's compensation to $20,000 per month in January 2022 and OES began compensating Mr. Conway $20,000 in March 2022. Below is a summary of wages and management fees:

		Three months ended March 31,
		2022			2021
CEO, parent		$	390,000			$	279,999
President, subsidiary (resigned July 2021)			-				35,008
Total		$	390,000			$	315,008

Stock based compensation for the three months ended March 31, 2022, of $136,429 is comprised of the following:

	●	5,000,000 shares of common stock issued in the aggregate to two employees pursuant to their offers of employment dated March 31, 2021. The shares were valued at $0.027 per share. During the three months ended March 31, 2022, the Company included $135,000 in stock compensation expense.
	●	$1,249 of amortization of stock compensation for shares issued in April 2021.

Stock based compensation for the three months ended March 31, 2021, of $4,902,000 is comprised of the following stock issuances:

	●	10,000,000 shares issued for services. The shares were valued at $0.0056 per share, the date the Company agreed to issue the shares. During the three months ended March 31, 2021, the Company included $56,000 in stock compensation expense.
	●	10,000,000 shares issued pursuant to a consulting agreement dated February 24, 2021 (see Note 11). The shares were valued at $0.2386 per share. During the three months ended March 31, 2021, the Company included $2,386,000 in stock compensation expense.
	●	5,000,000 shares of common stock to be issued in the aggregate to two new employees pursuant to their offers of employment dated March 31, 2021. The shares were valued at $0.23 per share. During the three months ended March 31, 2021, the Company included $460,000 in stock compensation expense for the 5,000,000 shares of common stock to be issued. The shares were issued in April 2021.
	●	Issuance of 2,000 shares (1,800 were issued to the Company's CEO) of Series E Preferred Stock, with a redemption value of $1,000 per share, resulting in stock compensation expense of $2,000,000 ($1,800,000 related party) for the three months ended March 31, 2021.

Salaries, taxes and benefits increased for the three months ended March 31, 2022, compared to the same period in 2021. The increase was a result of the current period including $246,435 of expenses related to OES. These additional costs were offset by a reduction in PCTI''s expenses of $73,734. OES now has annual gross payroll of approximately $512,000 and an additional $351,000 on an annual basis of personnel focused on the Company's battery storage vertical. Ozop Engineering and Design ("OED") has hired three employees effective April 1, 2022, with an aggregate annual compensation of $302,000.

Professional and consulting fees increased for the three months ended March 31, 2022, compared to March 31, 2021. The increase was due to increases in accounting and auditing expenses of Ozop in the current period, consultants engaged on the second quarter of 2021 by both Ozop Capital Partners and OES as we initiate each of their business plans regarding electric vehicles and distribution of renewable energy products, respectively.

Advertising and marketing expenses decreased for the three months ended March 31, 2022, compared to March 31, 2021. The decrease was related to marketing programs during 2021, including brand awareness programs for both PCTI and Ozop.

Rent and office expense (including supplies, utilities and internet costs) increased for the three months ended March 31, 2022, compared to the three months ended March 31, 2021. The increase was the result of including in the current period, rent and office expense of approximately $45,734 for OES. The Company estimates that the monthly OES rent and office expense for the California operation to be approximately $18,000 per month.

Insurance expense increased for the three months ended March 31, 2022, compared to the three months ended March 31, 2021. The increase was the result of including in the current period, insurance expense of approximately $80,834 for OES. The Company estimates that the monthly OES insurance expense for the California operation to be approximately $24,000 per month.

Other Income (Expenses)

Other income, net was $389,982 for the three months ended March 31, 2022, compared to other expenses, net, for the three months ended March 31, 2021, of $204,271,543, respectively, and were as follows:

		Three months ended March 31,
		2022			2021
Interest expense		$	3,975,221			$	40,654,750
(Gain) loss on change in fair value of derivatives			(4,365,203	)			52,197,902
Debt restructure expense			-				16,450,000
Loss on extinguishment of debt			-				94,968,892
Total other (income) expense, net		$	(389,982	)		$	204,271,543

The decrease in other expense for the three months ended March 31, 2022, is primarily a result expenses for the three months ended March 31, 2021, including the loss on extinguishment of debt related to the market value of shares of common stock issued in excess of the debt and accrued interest extinguished and 175,000,000 shares of restricted common stock issued related to the restructure of the deferred liability (see Note 9). The shares were valued at $0.094 per share and the Company recognized $16,450,000 of restructuring costs. Included in interest expense for the three months ended March 31, 2021, is the initial expense of $38,907,939 of fair value related to the issuance of 300,000,000 warrants. For the three months ended March 31, 2022, the Company recognized a gain on the change in the fair value of derivatives compared to a loss of $52,197,902 for the three months ended March 31, 2021.

Net loss

The net loss for the three months ended March 31, 2022, was $1,381,469 compared to $209,492,368 for the three months ended March 31, 2021. The decrease in the loss was primarily a result of a decrease in other expenses of $204,661,525, a decrease of $4,765,751 in stock-based compensation expenses as well as the operating results discussed above.

Liquidity and Capital Resources

Currently, our current capital and our other existing resources will be sufficient to provide the working capital needed for our current business, however, additional capital will be required to meet our debt obligations, and to further expand our business. We may be unable to obtain the additional capital required. If we are unable to generate capital or raise additional funds when required it will have a negative impact on our business development and financial results. These conditions raise substantial doubt about our ability to continue as a going concern as well as our recurring losses from operations, deficit in equity, and the need to raise additional capital to fund operations. This "going concern" could impair our ability to finance our operations through the sale of debt or equity securities. Management's plans in regard to these factors are discussed below and also in Note 2 to the condensed consolidated financial statements filed herein.

As of March 31, 2022, we had cash of $3,636,662 as compared to $6,767,167 at December 31, 2021. As of March 31, 2022, we had current liabilities of $38,384,123 (including $16,601,498 of non-cash derivative liabilities), compared to current assets of $8,898,282, which resulted in a working capital deficit of $29,485,841. The current liabilities are comprised of accounts payable, accrued expenses, convertible debt, derivative liabilities, customer deposits, lease obligations and notes payable.

In December 2019, a novel strain of coronavirus(COVID-19) emerged. Because COVID-19 infections have been reported throughout the United States, certain federal, state and local governmental authorities have issued stay-at-home orders, proclamations and/or directives aimed at minimizing the spread of COVID-19. The ultimate impact of the COVID-19 pandemicon the Company's operations is unknown and will depend on future developments, which are highly uncertain and cannot be predicted with confidence, including the duration of the COVID-19 outbreak, new information which may emerge concerning the severity of the COVID-19 pandemic, and any additional preventative and protective actions that governments, or the Company, may direct, which may result in an extended period of continued business disruption, and reduced operations. Any resulting financial impact cannot be reasonably estimated at this time but it may have a material adverse impact on our business, financial condition and results of operations. Management expects that its business will be impacted to some degree, but the significance of the impact of the COVID-19 outbreak on the Company's business and the duration for which it may have an impact cannot be determined at this time.

Operating Activities

For the three months ended March 31, 2022, net cash used in operating activities was $3,090,505 compared to $966,126 for the three months ended March 31, 2021. For the three months ended March 31, 2022, our net cash used in operating activities was primarily attributable to the net loss of $1,381.469, adjusted by non- cash interest expense of $3,379,121, stock-based compensation of $136,249 and the non-cash expenses of interest and amortization and depreciation of $62,532. This was offset by the gain on the fair value changes in derivatives related to warrants and convertible notes of $4,365,203. Net changes of $921,735 in operating assets and liabilities increased the cash used in operating activities.

For the three months ended March 31, 2021, our net cash used in operating activities was primarily attributable to the net loss of $209,492,368, adjusted by loss on debt extinguishment of $94,968,892, non- cash interest expense of $40,414,627 (including $38,907,939 for the initial fair value of the 300,000,000 warrants issued), losses on the fair value changes in derivatives related to warrants and convertible notes of $52,197,902, debt restructuring costs of $16,450,000, stock-based compensation of $4,902,000 and the non-cash expenses of interest and amortization and depreciation of $8,327. Net changes of $415,506 in operating assets and liabilities reduced the cash used in operating activities.

Investing Activities

For the three months ended March 31, 2022, the net cash used in investing activities was $40,000, compared to $35,306 for the three months ended March 31, 2021. The amounts for both periods were a result of the Company purchasing office furniture and equipment.

Financing Activities

For the three months ended March 31, 2022, there were no financing activities. For the three months ended March 31, 2021, the net cash provided by financing activities was $8,985,320. During the three months ended March 31, 2021, we received $12,000,000 of proceeds from the issuances of $13,30,000 face value of promissory notes. During the three months ended March 31, 2021, the Company redeemed 3,000 shares of the Series E Preferred Stock for $3,000,000, repaid $3,089 of notes payable and $11,591 to shareholders.

OFF BALANCE SHEET ARRANGEMENTS

We have no off-balance sheet arrangements including arrangements that would affect our liquidity, capital resources, market risk support and credit risk support or other benefits.

Critical Accounting Policies

Our significant accounting policies are described in more details in the notes to our financial statements appearing elsewhere in this Quarterly Report on Form 10-Q. We believe the following accounting policies to be most critical to the judgement and estimates used in the preparation of our unaudited condensed consolidated financial statements:

Basis of Presentation

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial statements and with the instructions to Form 10-Q and Article 8 of Regulation S-X of the SEC. Accordingly, they do not contain all information and footnotes required by accounting principles generally accepted in the United States of America for annual financial statements. In the opinion of the Company's management, the accompanying unaudited condensed consolidated financial statements contain all the adjustments necessary (consisting only of normal recurring accruals) to present the financial position of the Company as of March 31, 2022, and the results of operations and cash flows for the periods presented. The results of operations for the three months ended March 31, 2022, are not necessarily indicative of the operating results for the full fiscal year or any future period. These unaudited condensed consolidated financial statements should be read in conjunction with the financial statements and related notes thereto included in the Company's Annual Report on Form 10-K/A filed on April 26, 2022. The unaudited condensed consolidated financial statements of the Company include the consolidated accounts of the Company and its' wholly owned subsidiaries; PCTI, Ozop LLC, Ozop HK and Spinus. All intercompany accounts and transactions have been eliminated in consolidation.

Use of Estimates

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amount of revenues and expenses during the reported period. Actual results could differ from those estimates.

Revenue Recognition

Effective January 1, 2018, the Company adopted ASC 606 - Revenue from Contracts with Customers. Under ASC 606, the Company recognizes revenue from the commercial sales of products, licensing agreements and contracts to perform pilot studies by applying the following steps: (1) identify the contract with a customer; (2) identify the performance obligations in the contract; (3) determine the transaction price; (4) allocate the transaction price to each performance obligation in the contract; and (5) recognize revenue when each performance obligation is satisfied. For the comparative periods, revenue has not been adjusted and continues to be reported under ASC 605 - Revenue Recognition. Under ASC 605, revenue is recognized when the following criteria are met: (1) persuasive evidence of an arrangement exists; (2) the performance of service has been rendered to a customer or delivery has occurred; (3) the amount of fee to be paid by a customer is fixed and determinable; and (4) the collectability of the fee is reasonably assured. There was no impact on the Company's financial statements as a result of adopting Topic 606 for the three months ended March 31, 2022, and 2021.

Earnings (Loss) Per Share

The Company computes net loss per share in accordance with FASB ASC 260, "Earnings per Share." ASC 260 requires presentation of both basic and diluted earnings per share (EPS) on the face of the statement of operations. Basic EPS is computed by dividing net income (loss) available to common shareholders by the weighted average number of common shares outstanding during the period. Diluted EPS gives effect to all dilutive potential common shares outstanding during the period including stock options, using the treasury stock method, and convertible notes and stock warrants, using the if-converted method. In computing diluted EPS, the average stock price for the period is used in determining the number of shares assumed to be purchased from the exercise of stock options, warrants and conversion of convertible notes. Diluted EPS excludes all dilutive potential common shares if their effect is anti-dilutive.

Item 3. Quantitative and Qualitative Disclosures about Market Risk.

Not Applicable.

Item 4. Controls and Procedures.

Disclosure Controls and Procedures

We maintain disclosure controls and procedures, as defined in Rule 13a-15(e) promulgated under the Securities Exchange Act of 1934 (the "Exchange Act"), that are designed to ensure that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission's rules and forms and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosure.

We carried out an evaluation, under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, of the effectiveness of our disclosure controls and procedures as of March 31, 2022. Based on the evaluation of these disclosure controls and procedures, and in light of the material weaknesses found in our internal controls over financial reporting, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were not effective for the reasons discussed below.

A material weakness is a deficiency, or combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the Company's annual or interim financial statements will not be prevented or detected on a timely basis. In its assessment of the effectiveness of internal control over financial reporting as of March 31, 2022, the Company determined that there were control deficiencies that constituted material weaknesses, as described below.

	1.	We do not have an Audit Committee - While not being legally obligated to have an audit committee, it is the management's view that such a committee, including a financial expert member, is an utmost important entity level control over the Company's financial statement. Currently the Board of Directors acts in the capacity of the Audit Committee, and does not include a member that is considered to be independent of management to provide the necessary oversight over management's activities.
	2.	We did not maintain appropriate cash controls - As of March 31, 2022, the Company has not maintained sufficient internal controls over financial reporting for cash, including failure to segregate cash handling and accounting functions, and did not require dual signatures on the Company's bank accounts.

Accordingly, the Company concluded that these control deficiencies resulted in a reasonable possibility that a material misstatement of the annual or interim financial statements will not be prevented or detected on a timely basis by the company's internal controls.

Our management, including our Chief Executive Officer and our Chief Financial Officer, does not expect that our disclosure controls and procedures or our internal controls will prevent all error and all fraud. A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Further, the design of a control system must reflect the fact that there are resource constraints and the benefits of controls must be considered relative to their costs. Due to the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within our company have been detected.

Changes in Internal Controls over Financial Reporting

There has been no change in our internal control over financial reporting occurred during the three months ended March 31, 2022, that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

PART II. OTHER INFORMATION

Item 1. LEGAL PROCEEDINGS

We know of no material, existing or pending legal proceedings against our Company, nor are we involved as a plaintiff in any material proceeding or pending litigation. There are no proceedings in which any of our directors, officers or affiliates, or any registered or beneficial shareholder, is an adverse party or has a material interest adverse to our interest.

Item 1A. RISK FACTORS

Not applicable for smaller reporting companies.

Item 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

The following represents all shares issued during the quarter ended March 31, 2022:

On January 14, 2022, the Company issued 2,500,000 shares pursuant to an employment agreement.

On January 14, 2022, the Company issued 2,500,000 shares pursuant to an employment agreement.

The Company issued the foregoing securities in reliance on an exemption from registration provided by Section 4(a)(2) of the Securities Act of 1933, as amended, and/or Rule 506(b) promulgated thereunder, as there was no general solicitation to the investors and the transactions did not involve a public offering.

Item 3. DEFAULTS UPON SENIOR SECURITIES

On March 17, 2021, the Company entered into a 12%, $11,110,000 face value promissory note with a third- party lender with a maturity date of March 17, 2022. This note is now in default. As of March 31, 2022, the principal of $11,110,000 and the accrued interest of $1,362,421 is due. The Company is in discussions with the lender regarding the extension of the maturity date of this note.

On February 9, 2021, the Company entered into a 12%, $2,200,000 face value promissory note with a third- party lender with a maturity date of February 9, 2022. This note is now in default. As of March 31, 2022, the principal of $2,200,000 and the accrued interest of $295,825 is due. The Company is in discussions with the lender regarding the extension of the maturity date of this note.

On November 13, 2020, the Company entered into a 12%, $1,000,000 face value promissory note with a third-party due November 13, 2021. This note is now in default. As of March 31, 2022, the principal is $1,000,000 and the accrued interest of $194,630 is due. The Company is in discussions with the lender regarding the extension of the maturity date of this note.

Item 4. MINE SAFETY DISCLOSURE

Not applicable.

Item 5. OTHER INFORMATION

	(a)	None.
	(b)	During the quarter ended March 31, 2022, there have not been any material changes to the procedures by which security holders may recommend nominees to the Board of Directors.

Item 6. EXHIBITS

The following documents are filed as part of this report:

Exhibit No.		Description
2.1		Share Exchange Agreement dated April 5, 2018 by and among Newmarkt Corp., the shareholders of Ozop Surgical, Inc., Ozop Surgical, Inc. and Denis Razvodovskij (Incorporated by reference to Exhibit 2.1 of the Current Report on Form 8-K filed on April 19, 2018).
2.2		Stock Purchase Agreement dated June 26, 2020, by and among Ozop Surgical Corp., Power Conversion Technologies, Inc. and Catherine Chis (Incorporated by reference to Exhibit 10.1 of the Current Report on Form 8-K filed on June 29, 2020).
2.3		Merger Agreement and Plan of Merger between Ozop Surgical Corp. and Ozop Surgical Name Change Subsidiary, Inc. (Incorporated by reference to Exhibit 2.1 of the Current Report on Form 8-K filed on November 13, 2020).
3.1		Articles of Incorporation (Incorporated by reference to our General Form for Registration of Securities on Form S-1 filed on August 1, 2016)
3.2		Bylaws (Incorporated by reference to our General Form for Registration of Securities on Form S-1 filed on August 1, 2016)
3.3		Certificate of Amendment of Amended and Restated Articles of Incorporation as filed with the Nevada Secretary of State on May 8, 2018 (Incorporated by reference to Exhibit 3.1 of the Current Report on Form 8-K filed on May 14, 2018).
3.4		Certificate of Designations for Series B Preferred Stock. (Incorporated by reference to Exhibit 3.1 of the Current Report on Form 8-K filed on April 2, 2019).
3.5		Amended and Restated Bylaws of Ozop Surgical Corp. adopted on May 22, 2019. (Incorporated by reference to Exhibit 3.2 of the Current Report on Form 8-K filed on May 22, 2019).
3.6		Amended and Restated Articles of Incorporation as filed with the Nevada Secretary of State on July 25, 2019. (Incorporated by reference to Exhibit 3.1 of the Current Report on Form 8-K filed on July 30, 2019).
3.7		Certificate of Designation of Series C Preferred Stock. (Incorporated by reference to Exhibit 3.1 of the Current Report on Form 8-K filed on September 24, 2019).
3.8		Certificate of Withdrawal of Series B Preferred Stock. (Incorporated by reference to Exhibit 3.2 of the Current Report on Form 8-K filed on September 24, 2019).
3.9		Amended and Restated Articles of Incorporation as filed with the Nevada Secretary of State on October 29, 2019. (Incorporated by reference to Exhibit 3.2 of the Current Report on Form 8-K filed on October 31, 2019).

3.10		Amended and Restated Articles of Incorporation as filed with the Nevada Secretary of State on December 30, 2020, (Incorporated by reference to Exhibit 3.1 of the Current Report on Form 8-K filed on December 31, 2019).
3.11		Amended and Restated Articles of Incorporation as filed with the Nevada Secretary of State on January 21, 2020. (Incorporated by reference to Exhibit 3.1 of the Current Report on Form 8-K filed on February 7, 2020).
3.12		Amended and Restated Certificate of Designation of Series C Preferred Stock. (Incorporated by reference to Exhibit 3.1 of the Current Report on Form 8-K filed on February 5, 2020).
3.13		Amendment to Certificate of Designation of Series C Preferred Stock dated July 7, 2020 (Incorporated by reference to Exhibit 3.1 of the Current Report on Form 8-K filed on July 10, 2020).
3.14		Certificate of Designation of Series D Preferred Stock dated July 7, 2020 (Incorporated by reference to Exhibit 3.2 of the Current Report on Form 8-K filed on July 10, 2020).
3.15		Certificate of Designation of Series E Preferred Stock dated July 7, 2020 (Incorporated by reference to Exhibit 3.3 of the Current Report on Form 8-K filed on July 10, 2020).
3.16		Articles of Incorporation of Ozop Surgical Name Change Subsidiary, Inc. (Incorporated by reference to Exhibit 3.1 of the Current Report on Form 8-K filed on November 13, 2020).
3.17		Articles of Merger between Ozop Surgical Corp. and Ozop Surgical Name Change Subsidiary, Inc. (Incorporated by reference to Exhibit 3.2 of the Current Report on Form 8-K filed on November 13, 2020).
3.18		Amended and Restated Certificate of Designation Series D Preferred Stock dated July 27, 2021 (Incorporated by reference to Exhibit 3.1 of the Current Report on Form 8-K filed on August 2, 2021).
3.19		Advisory agreement between Ozop Capital and RMA dated September 1, 2021 (Incorporated by reference to Exhibit 10.1 of the Current Report on Form 8-K filed on September 2, 2021).
10.1		Binding Letter of Intent dated February 28, 2020, by and between Ozop Surgical Corp. and Power Conversion Technologies, Inc, and Catherine Chis, (Incorporated by reference to Exhibit 10.1 of the Current Report on Form 8-K filed on February 28, 2020).
10.2+		Employment Agreement dated February 28, 2020, by and between Ozop Surgical Corp. and Brian Conway, (Incorporated by reference to Exhibit 10.3 of the Current Report on Form 8-K filed on February 28, 2020).
31.1*		Certification of Chief Executive Officer required by Rule 13a-14(1) or Rule 15d-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
31.2*		Certification of Chief Financial Officer required by Rule 13a-14(1) or Rule 15d-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
32.1*		Certification of Chief Executive Officer and the Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and Section 1350 of 18 U.S.C. 63
101.INS*		Inline XBRL Instance Document
101.SCH*		Inline XBRL Taxonomy Extension Schema Document
101.CAL*		Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF*		Inline XBRL Taxonomy Extension Definition Linkbase Document
101.LAB*		Inline XBRL Taxonomy Extension Label Linkbase Document
101.PRE*		Inline XBRL Taxonomy Extension Presentation Linkbase Document
104		Cover Page Interactive Data File (embedded within the Inline XBRL document)

* Filed herewith.

+ Management contract or compensatory plan or arrangement.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

Dated: May 16, 2022

/s/ Brian P Conway
Brian P. Conway
Chief Executive Officer
(principal executive officer)
(principal financial and accounting officer)

Public link

Please use the above public link if you want to share this noodl on another website.